date generated: 2023-08-30
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
| x | |
|---|---|
| 0610005C13Rik | 1.7086294 |
| 0610009B22Rik | -2.3583781 |
| 0610009E02Rik | -0.4921631 |
| 0610009L18Rik | -1.5061599 |
| 0610010K14Rik | -0.7608005 |
| 0610012G03Rik | -0.6314820 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 1604 |
| num_genes_in_profile | 17472 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8440 |
| num_profile_genes_not_in_sets | 9032 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: mouse_msigdb_reactome_2022-02-16.gmt| Gene sets metrics | |
|---|---|
| num_genesets | 1604 |
| num_genesets_excluded | 425 |
| num_genesets_included | 1179 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 50 gene sets
## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN | 10 | 1.41e-04 | -0.695 | 1.54e-03 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 1.95e-04 | 0.680 | 2.03e-03 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 6.32e-05 | 0.560 | 8.09e-04 |
| ENDOSOMAL VACUOLAR PATHWAY | 10 | 3.88e-03 | -0.527 | 2.56e-02 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 2.83e-03 | -0.520 | 1.97e-02 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 4.35e-06 | 0.511 | 8.55e-05 |
| RETINOID CYCLE DISEASE EVENTS | 10 | 7.39e-03 | -0.489 | 4.22e-02 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 6.40e-06 | -0.484 | 1.13e-04 |
| LGI ADAM INTERACTIONS | 14 | 2.77e-03 | 0.462 | 1.95e-02 |
| YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 11 | 9.97e-03 | 0.449 | 5.37e-02 |
| CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 5.16e-04 | -0.448 | 4.82e-03 |
| P75NTR REGULATES AXONOGENESIS | 10 | 1.52e-02 | -0.443 | 7.35e-02 |
| THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 15 | 3.18e-03 | -0.440 | 2.14e-02 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 1.16e-02 | 0.440 | 6.05e-02 |
| DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 1.13e-03 | 0.421 | 9.22e-03 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.75e-02 | -0.414 | 8.17e-02 |
| RORA ACTIVATES GENE EXPRESSION | 18 | 2.58e-03 | 0.410 | 1.86e-02 |
| MITOCHONDRIAL TRANSLATION | 93 | 1.33e-11 | -0.406 | 2.61e-09 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 2.00e-02 | -0.405 | 8.88e-02 |
| CRISTAE FORMATION | 31 | 1.04e-04 | -0.403 | 1.23e-03 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 1.53e-03 | -0.399 | 1.20e-02 |
| PENTOSE PHOSPHATE PATHWAY | 13 | 1.30e-02 | -0.398 | 6.52e-02 |
| METABOLISM OF POLYAMINES | 58 | 1.59e-07 | -0.398 | 6.05e-06 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 4.46e-04 | -0.398 | 4.28e-03 |
| NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 4.32e-07 | -0.398 | 1.34e-05 |
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 2.78e-03 | -0.396 | 1.95e-02 |
| ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 3.29e-08 | -0.396 | 1.69e-06 |
| SIGNALING BY LEPTIN | 10 | 3.01e-02 | 0.396 | 1.18e-01 |
| TIGHT JUNCTION INTERACTIONS | 17 | 4.74e-03 | -0.396 | 3.04e-02 |
| UNWINDING OF DNA | 12 | 1.86e-02 | -0.392 | 8.47e-02 |
| CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 47 | 3.49e-06 | -0.391 | 7.49e-05 |
| RESPIRATORY ELECTRON TRANSPORT | 102 | 1.02e-11 | -0.390 | 2.41e-09 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 1.49e-02 | -0.390 | 7.25e-02 |
| PHOSPHORYLATION OF THE APC C | 18 | 4.69e-03 | -0.385 | 3.03e-02 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 2.90e-03 | -0.385 | 2.01e-02 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 2.31e-03 | 0.384 | 1.70e-02 |
| GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 2.37e-04 | -0.381 | 2.45e-03 |
| SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 87 | 7.74e-10 | -0.381 | 5.71e-08 |
| METHYLATION | 11 | 2.99e-02 | -0.378 | 1.17e-01 |
| ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 1.83e-02 | 0.378 | 8.47e-02 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 9.17e-04 | 0.376 | 7.66e-03 |
| ORC1 REMOVAL FROM CHROMATIN | 68 | 8.69e-08 | -0.375 | 3.63e-06 |
| PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 3.73e-03 | -0.375 | 2.47e-02 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 2.50e-02 | -0.374 | 1.04e-01 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 7.83e-07 | -0.372 | 2.20e-05 |
| PROTEIN UBIQUITINATION | 70 | 7.66e-08 | -0.372 | 3.34e-06 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 4.22e-02 | -0.371 | 1.47e-01 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 6.98e-03 | -0.367 | 4.03e-02 |
| COMPLEX I BIOGENESIS | 56 | 2.06e-06 | -0.367 | 4.67e-05 |
| APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 71 | 9.26e-08 | -0.367 | 3.64e-06 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN | 10 | 1.41e-04 | -0.695000 | 1.54e-03 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 1.95e-04 | 0.680000 | 2.03e-03 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 6.32e-05 | 0.560000 | 8.09e-04 |
| ENDOSOMAL VACUOLAR PATHWAY | 10 | 3.88e-03 | -0.527000 | 2.56e-02 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 2.83e-03 | -0.520000 | 1.97e-02 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 4.35e-06 | 0.511000 | 8.55e-05 |
| RETINOID CYCLE DISEASE EVENTS | 10 | 7.39e-03 | -0.489000 | 4.22e-02 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 6.40e-06 | -0.484000 | 1.13e-04 |
| LGI ADAM INTERACTIONS | 14 | 2.77e-03 | 0.462000 | 1.95e-02 |
| YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 11 | 9.97e-03 | 0.449000 | 5.37e-02 |
| CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 5.16e-04 | -0.448000 | 4.82e-03 |
| P75NTR REGULATES AXONOGENESIS | 10 | 1.52e-02 | -0.443000 | 7.35e-02 |
| THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 15 | 3.18e-03 | -0.440000 | 2.14e-02 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 1.16e-02 | 0.440000 | 6.05e-02 |
| DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 1.13e-03 | 0.421000 | 9.22e-03 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.75e-02 | -0.414000 | 8.17e-02 |
| RORA ACTIVATES GENE EXPRESSION | 18 | 2.58e-03 | 0.410000 | 1.86e-02 |
| MITOCHONDRIAL TRANSLATION | 93 | 1.33e-11 | -0.406000 | 2.61e-09 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 2.00e-02 | -0.405000 | 8.88e-02 |
| CRISTAE FORMATION | 31 | 1.04e-04 | -0.403000 | 1.23e-03 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 1.53e-03 | -0.399000 | 1.20e-02 |
| PENTOSE PHOSPHATE PATHWAY | 13 | 1.30e-02 | -0.398000 | 6.52e-02 |
| METABOLISM OF POLYAMINES | 58 | 1.59e-07 | -0.398000 | 6.05e-06 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 4.46e-04 | -0.398000 | 4.28e-03 |
| NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 4.32e-07 | -0.398000 | 1.34e-05 |
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 2.78e-03 | -0.396000 | 1.95e-02 |
| ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 3.29e-08 | -0.396000 | 1.69e-06 |
| SIGNALING BY LEPTIN | 10 | 3.01e-02 | 0.396000 | 1.18e-01 |
| TIGHT JUNCTION INTERACTIONS | 17 | 4.74e-03 | -0.396000 | 3.04e-02 |
| UNWINDING OF DNA | 12 | 1.86e-02 | -0.392000 | 8.47e-02 |
| CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 47 | 3.49e-06 | -0.391000 | 7.49e-05 |
| RESPIRATORY ELECTRON TRANSPORT | 102 | 1.02e-11 | -0.390000 | 2.41e-09 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 1.49e-02 | -0.390000 | 7.25e-02 |
| PHOSPHORYLATION OF THE APC C | 18 | 4.69e-03 | -0.385000 | 3.03e-02 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 2.90e-03 | -0.385000 | 2.01e-02 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 2.31e-03 | 0.384000 | 1.70e-02 |
| GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 2.37e-04 | -0.381000 | 2.45e-03 |
| SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 87 | 7.74e-10 | -0.381000 | 5.71e-08 |
| METHYLATION | 11 | 2.99e-02 | -0.378000 | 1.17e-01 |
| ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 1.83e-02 | 0.378000 | 8.47e-02 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 9.17e-04 | 0.376000 | 7.66e-03 |
| ORC1 REMOVAL FROM CHROMATIN | 68 | 8.69e-08 | -0.375000 | 3.63e-06 |
| PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 3.73e-03 | -0.375000 | 2.47e-02 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 2.50e-02 | -0.374000 | 1.04e-01 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 7.83e-07 | -0.372000 | 2.20e-05 |
| PROTEIN UBIQUITINATION | 70 | 7.66e-08 | -0.372000 | 3.34e-06 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 4.22e-02 | -0.371000 | 1.47e-01 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 6.98e-03 | -0.367000 | 4.03e-02 |
| COMPLEX I BIOGENESIS | 56 | 2.06e-06 | -0.367000 | 4.67e-05 |
| APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 71 | 9.26e-08 | -0.367000 | 3.64e-06 |
| RHOBTB3 ATPASE CYCLE | 10 | 4.50e-02 | -0.366000 | 1.54e-01 |
| SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 1.68e-03 | 0.363000 | 1.29e-02 |
| RAB GERANYLGERANYLATION | 58 | 1.84e-06 | -0.362000 | 4.25e-05 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 20 | 5.09e-03 | -0.362000 | 3.19e-02 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 11 | 3.78e-02 | -0.362000 | 1.36e-01 |
| RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 7.55e-04 | -0.361000 | 6.74e-03 |
| ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 6.13e-04 | -0.361000 | 5.60e-03 |
| AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 54 | 4.56e-06 | -0.361000 | 8.81e-05 |
| INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 6.59e-03 | -0.360000 | 3.87e-02 |
| REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 64 | 6.91e-07 | -0.359000 | 1.99e-05 |
| RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 4.38e-12 | -0.359000 | 1.29e-09 |
| GLUTATHIONE CONJUGATION | 29 | 8.68e-04 | -0.357000 | 7.42e-03 |
| NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 1.08e-03 | 0.357000 | 8.93e-03 |
| ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 7.57e-03 | -0.354000 | 4.27e-02 |
| ACTIVATION OF SMO | 16 | 1.44e-02 | 0.353000 | 7.10e-02 |
| MITOCHONDRIAL PROTEIN IMPORT | 63 | 1.23e-06 | -0.353000 | 3.38e-05 |
| DNA REPLICATION PRE INITIATION | 80 | 5.29e-08 | -0.352000 | 2.49e-06 |
| RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 1.83e-02 | -0.352000 | 8.47e-02 |
| ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 2.98e-06 | -0.352000 | 6.56e-05 |
| E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 1.45e-05 | -0.351000 | 2.19e-04 |
| TRIGLYCERIDE CATABOLISM | 14 | 2.38e-02 | -0.349000 | 1.01e-01 |
| INTERLEUKIN 6 SIGNALING | 10 | 5.63e-02 | 0.349000 | 1.78e-01 |
| APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 83 | 4.26e-08 | -0.348000 | 2.09e-06 |
| INTERLEUKIN 12 SIGNALING | 36 | 3.04e-04 | -0.348000 | 3.04e-03 |
| S PHASE | 154 | 1.33e-13 | -0.346000 | 7.76e-11 |
| DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 60 | 3.93e-06 | -0.344000 | 8.13e-05 |
| PROTEIN METHYLATION | 17 | 1.42e-02 | -0.344000 | 7.01e-02 |
| TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 2.42e-03 | -0.344000 | 1.78e-02 |
| DNA REPLICATION | 122 | 5.78e-11 | -0.343000 | 7.23e-09 |
| HIV TRANSCRIPTION INITIATION | 45 | 6.91e-05 | -0.343000 | 8.49e-04 |
| GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 13 | 3.38e-02 | -0.340000 | 1.25e-01 |
| DEGRADATION OF DVL | 56 | 1.09e-05 | -0.340000 | 1.72e-04 |
| INSULIN RECEPTOR RECYCLING | 20 | 8.66e-03 | -0.339000 | 4.72e-02 |
| PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 2.85e-02 | -0.338000 | 1.14e-01 |
| CRMPS IN SEMA3A SIGNALING | 16 | 1.95e-02 | 0.337000 | 8.68e-02 |
| THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 69 | 1.48e-06 | -0.335000 | 3.72e-05 |
| MET ACTIVATES RAP1 AND RAC1 | 10 | 6.65e-02 | -0.335000 | 1.97e-01 |
| DEGRADATION OF AXIN | 54 | 2.11e-05 | -0.335000 | 3.10e-04 |
| G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 1.20e-02 | -0.333000 | 6.18e-02 |
| REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 2.89e-05 | -0.332000 | 4.11e-04 |
| DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 60 | 8.98e-06 | -0.331000 | 1.47e-04 |
| SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 3.87e-02 | 0.331000 | 1.38e-01 |
| PYRUVATE METABOLISM | 27 | 2.95e-03 | -0.331000 | 2.02e-02 |
| NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 1.32e-03 | 0.328000 | 1.06e-02 |
| MATURATION OF NUCLEOPROTEIN | 10 | 7.48e-02 | -0.325000 | 2.16e-01 |
| NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 5.20e-04 | 0.325000 | 4.82e-03 |
| THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 1.97e-13 | -0.325000 | 7.76e-11 |
| DEGRADATION OF GLI1 BY THE PROTEASOME | 58 | 1.99e-05 | -0.324000 | 2.97e-04 |
| RAS PROCESSING | 24 | 6.10e-03 | -0.323000 | 3.63e-02 |
| ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 6.33e-02 | -0.323000 | 1.91e-01 |
| NGF STIMULATED TRANSCRIPTION | 36 | 8.24e-04 | -0.322000 | 7.14e-03 |
| PERK REGULATES GENE EXPRESSION | 28 | 3.24e-03 | -0.321000 | 2.17e-02 |
| CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 3.67e-07 | -0.321000 | 1.24e-05 |
| EARLY PHASE OF HIV LIFE CYCLE | 13 | 4.51e-02 | -0.321000 | 1.54e-01 |
| STABILIZATION OF P53 | 55 | 4.02e-05 | -0.320000 | 5.51e-04 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 1.37e-02 | -0.319000 | 6.82e-02 |
| CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 3.27e-02 | -0.319000 | 1.23e-01 |
| PHASE II CONJUGATION OF COMPOUNDS | 63 | 1.32e-05 | -0.317000 | 2.03e-04 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 5.70e-02 | -0.317000 | 1.78e-01 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 3.99e-02 | 0.317000 | 1.42e-01 |
| DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 53 | 6.64e-05 | 0.317000 | 8.33e-04 |
| INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 4.11e-02 | -0.315000 | 1.44e-01 |
| PROCESSING OF SMDT1 | 16 | 2.91e-02 | -0.315000 | 1.15e-01 |
| REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 8.64e-02 | 0.313000 | 2.38e-01 |
| DNA STRAND ELONGATION | 32 | 2.23e-03 | -0.312000 | 1.66e-02 |
| AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 27 | 4.99e-03 | 0.312000 | 3.15e-02 |
| ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 24 | 8.21e-03 | -0.312000 | 4.54e-02 |
| RUNX3 REGULATES NOTCH SIGNALING | 13 | 5.19e-02 | 0.311000 | 1.68e-01 |
| O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 36 | 1.28e-03 | 0.310000 | 1.04e-02 |
| CELLULAR RESPONSE TO HYPOXIA | 73 | 4.65e-06 | -0.310000 | 8.84e-05 |
| REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 69 | 8.48e-06 | -0.310000 | 1.43e-04 |
| REGULATION OF BACH1 ACTIVITY | 11 | 7.58e-02 | -0.309000 | 2.18e-01 |
| PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 3.23e-02 | 0.309000 | 1.22e-01 |
| EUKARYOTIC TRANSLATION INITIATION | 115 | 1.08e-08 | -0.309000 | 6.39e-07 |
| INTERFERON ALPHA BETA SIGNALING | 56 | 6.86e-05 | -0.308000 | 8.49e-04 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 2.24e-03 | -0.307000 | 1.66e-02 |
| MITOTIC G1 PHASE AND G1 S TRANSITION | 141 | 3.46e-10 | -0.306000 | 2.92e-08 |
| INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 4.42e-03 | -0.305000 | 2.89e-02 |
| MET ACTIVATES PTK2 SIGNALING | 28 | 5.23e-03 | 0.305000 | 3.21e-02 |
| APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 1.00e-02 | -0.304000 | 5.37e-02 |
| TRANSLATION | 287 | 1.10e-18 | -0.303000 | 1.30e-15 |
| PROTEIN LOCALIZATION | 157 | 6.13e-11 | -0.303000 | 7.23e-09 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 17 | 3.09e-02 | -0.302000 | 1.20e-01 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 3.10e-02 | 0.302000 | 1.20e-01 |
| ACTIVATION OF RAC1 | 13 | 6.03e-02 | -0.301000 | 1.84e-01 |
| DARPP 32 EVENTS | 23 | 1.27e-02 | -0.300000 | 6.46e-02 |
| DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 79 | 4.15e-06 | -0.300000 | 8.44e-05 |
| APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 1.01e-01 | -0.300000 | 2.57e-01 |
| BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.30e-02 | -0.299000 | 6.52e-02 |
| SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 8.93e-08 | -0.299000 | 3.63e-06 |
| BUDDING AND MATURATION OF HIV VIRION | 27 | 7.41e-03 | -0.298000 | 4.22e-02 |
| REGULATION OF PTEN STABILITY AND ACTIVITY | 68 | 2.21e-05 | -0.298000 | 3.22e-04 |
| INTERLEUKIN 37 SIGNALING | 18 | 2.95e-02 | 0.296000 | 1.16e-01 |
| ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 5.87e-03 | -0.296000 | 3.55e-02 |
| DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 6.54e-02 | -0.295000 | 1.95e-01 |
| APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 22 | 1.68e-02 | -0.295000 | 7.93e-02 |
| OTHER SEMAPHORIN INTERACTIONS | 19 | 2.66e-02 | 0.294000 | 1.08e-01 |
| KINESINS | 47 | 5.02e-04 | 0.293000 | 4.74e-03 |
| INTERLEUKIN 12 FAMILY SIGNALING | 43 | 8.96e-04 | -0.293000 | 7.58e-03 |
| CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 2.72e-02 | -0.293000 | 1.10e-01 |
| REGULATION OF TLR BY ENDOGENOUS LIGAND | 14 | 5.82e-02 | -0.292000 | 1.80e-01 |
| NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 1.27e-04 | -0.291000 | 1.41e-03 |
| COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 2.92e-03 | -0.291000 | 2.02e-02 |
| FCERI MEDIATED NF KB ACTIVATION | 77 | 1.05e-05 | -0.290000 | 1.68e-04 |
| BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 8.30e-02 | -0.289000 | 2.32e-01 |
| REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 85 | 4.34e-06 | -0.288000 | 8.55e-05 |
| G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 24 | 1.46e-02 | -0.288000 | 7.13e-02 |
| PHASE 2 PLATEAU PHASE | 12 | 8.41e-02 | 0.288000 | 2.35e-01 |
| FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 4.74e-02 | -0.286000 | 1.58e-01 |
| PYROPTOSIS | 21 | 2.34e-02 | -0.286000 | 1.00e-01 |
| RNA POLYMERASE III CHAIN ELONGATION | 18 | 3.63e-02 | -0.285000 | 1.31e-01 |
| RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 96 | 1.46e-06 | -0.285000 | 3.72e-05 |
| PURINE CATABOLISM | 16 | 4.89e-02 | -0.284000 | 1.61e-01 |
| SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 5.70e-02 | 0.284000 | 1.78e-01 |
| DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 83 | 7.90e-06 | -0.284000 | 1.35e-04 |
| RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 1.61e-02 | -0.284000 | 7.73e-02 |
| SULFUR AMINO ACID METABOLISM | 23 | 1.87e-02 | -0.283000 | 8.49e-02 |
| TERMINATION OF TRANSLESION DNA SYNTHESIS | 31 | 6.57e-03 | -0.282000 | 3.87e-02 |
| ANTIGEN PROCESSING CROSS PRESENTATION | 99 | 1.27e-06 | -0.282000 | 3.41e-05 |
| RRNA PROCESSING IN THE MITOCHONDRION | 10 | 1.23e-01 | -0.281000 | 2.95e-01 |
| PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 3.38e-02 | -0.281000 | 1.25e-01 |
| DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 6.86e-02 | 0.281000 | 2.01e-01 |
| METABOLISM OF COFACTORS | 19 | 3.41e-02 | -0.281000 | 1.25e-01 |
| SIGNALING BY FGFR2 IIIA TM | 19 | 3.58e-02 | -0.278000 | 1.30e-01 |
| MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 7.36e-03 | -0.278000 | 4.22e-02 |
| FORMATION OF APOPTOSOME | 10 | 1.28e-01 | -0.278000 | 3.00e-01 |
| PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 17 | 4.81e-02 | -0.277000 | 1.60e-01 |
| FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 4.95e-04 | -0.277000 | 4.70e-03 |
| REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 9.05e-03 | 0.275000 | 4.92e-02 |
| ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 6.48e-02 | -0.275000 | 1.94e-01 |
| HEDGEHOG LIGAND BIOGENESIS | 62 | 1.78e-04 | -0.275000 | 1.91e-03 |
| TRANSLESION SYNTHESIS BY POLK | 17 | 5.02e-02 | -0.274000 | 1.64e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 8.69e-02 | 0.274000 | 2.39e-01 |
| EUKARYOTIC TRANSLATION ELONGATION | 88 | 8.99e-06 | -0.274000 | 1.47e-04 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.01e-01 | -0.273000 | 2.57e-01 |
| TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 6.92e-03 | -0.272000 | 4.03e-02 |
| G1 S DNA DAMAGE CHECKPOINTS | 66 | 1.37e-04 | -0.272000 | 1.51e-03 |
| POLYMERASE SWITCHING | 14 | 7.89e-02 | -0.271000 | 2.22e-01 |
| TRANSLESION SYNTHESIS BY POLH | 19 | 4.12e-02 | -0.271000 | 1.44e-01 |
| MRNA CAPPING | 29 | 1.22e-02 | -0.269000 | 6.24e-02 |
| REGULATION OF RAS BY GAPS | 67 | 1.43e-04 | -0.269000 | 1.55e-03 |
| HS GAG DEGRADATION | 21 | 3.35e-02 | 0.268000 | 1.25e-01 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 1.45e-01 | -0.266000 | 3.24e-01 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 1.26e-01 | -0.266000 | 2.98e-01 |
| NEUREXINS AND NEUROLIGINS | 54 | 7.62e-04 | 0.265000 | 6.76e-03 |
| FORMATION OF INCISION COMPLEX IN GG NER | 43 | 2.67e-03 | -0.265000 | 1.90e-02 |
| IRON UPTAKE AND TRANSPORT | 52 | 9.76e-04 | -0.264000 | 8.11e-03 |
| LAGGING STRAND SYNTHESIS | 20 | 4.12e-02 | -0.264000 | 1.44e-01 |
| HYALURONAN METABOLISM | 16 | 6.80e-02 | 0.264000 | 2.00e-01 |
| INTERLEUKIN 7 SIGNALING | 19 | 4.68e-02 | 0.263000 | 1.57e-01 |
| CLEC7A DECTIN 1 SIGNALING | 95 | 9.54e-06 | -0.263000 | 1.54e-04 |
| GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 1.31e-01 | -0.263000 | 3.05e-01 |
| DNA DAMAGE BYPASS | 47 | 1.87e-03 | -0.262000 | 1.42e-02 |
| BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 7.17e-02 | -0.260000 | 2.09e-01 |
| FGFR2 MUTANT RECEPTOR ACTIVATION | 27 | 1.95e-02 | -0.260000 | 8.68e-02 |
| NRAGE SIGNALS DEATH THROUGH JNK | 55 | 9.00e-04 | 0.259000 | 7.58e-03 |
| GP1B IX V ACTIVATION SIGNALLING | 11 | 1.38e-01 | 0.259000 | 3.16e-01 |
| INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 4.57e-02 | 0.258000 | 1.54e-01 |
| RHOC GTPASE CYCLE | 74 | 1.25e-04 | 0.258000 | 1.41e-03 |
| RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 3.23e-02 | -0.258000 | 1.22e-01 |
| NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 4.67e-02 | 0.257000 | 1.57e-01 |
| RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 7.79e-03 | -0.256000 | 4.38e-02 |
| INTERLEUKIN 15 SIGNALING | 12 | 1.25e-01 | 0.256000 | 2.96e-01 |
| MITOPHAGY | 29 | 1.71e-02 | -0.256000 | 8.05e-02 |
| POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 2.70e-02 | -0.256000 | 1.09e-01 |
| RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 85 | 4.68e-05 | -0.256000 | 6.28e-04 |
| PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 1.61e-03 | -0.255000 | 1.24e-02 |
| RHOB GTPASE CYCLE | 68 | 2.79e-04 | 0.255000 | 2.86e-03 |
| ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 3.46e-02 | -0.255000 | 1.27e-01 |
| TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 7.87e-02 | -0.254000 | 2.22e-01 |
| CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 1.28e-01 | -0.254000 | 3.00e-01 |
| PINK1 PRKN MEDIATED MITOPHAGY | 22 | 3.95e-02 | -0.254000 | 1.41e-01 |
| HEME BIOSYNTHESIS | 13 | 1.14e-01 | -0.253000 | 2.79e-01 |
| REGULATION OF EXPRESSION OF SLITS AND ROBOS | 165 | 2.24e-08 | -0.252000 | 1.20e-06 |
| RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 5.07e-02 | 0.252000 | 1.65e-01 |
| SELENOAMINO ACID METABOLISM | 110 | 5.04e-06 | -0.252000 | 9.06e-05 |
| REGULATED NECROSIS | 46 | 3.12e-03 | -0.252000 | 2.11e-02 |
| DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 34 | 1.11e-02 | -0.252000 | 5.84e-02 |
| G2 M CHECKPOINTS | 136 | 4.10e-07 | -0.252000 | 1.31e-05 |
| METABOLISM OF PORPHYRINS | 19 | 5.81e-02 | -0.251000 | 1.80e-01 |
| NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 15 | 9.25e-02 | 0.251000 | 2.46e-01 |
| RNA POLYMERASE I PROMOTER ESCAPE | 48 | 2.65e-03 | -0.251000 | 1.89e-02 |
| DERMATAN SULFATE BIOSYNTHESIS | 11 | 1.50e-01 | 0.250000 | 3.34e-01 |
| CS DS DEGRADATION | 14 | 1.06e-01 | 0.250000 | 2.65e-01 |
| PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 7.63e-05 | 0.248000 | 9.27e-04 |
| HOST INTERACTIONS OF HIV FACTORS | 126 | 1.54e-06 | -0.248000 | 3.78e-05 |
| ENOS ACTIVATION | 11 | 1.54e-01 | -0.248000 | 3.39e-01 |
| CELLULAR RESPONSE TO STARVATION | 147 | 2.30e-07 | -0.247000 | 8.22e-06 |
| TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 1.23e-01 | -0.247000 | 2.94e-01 |
| GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 1.10e-04 | -0.246000 | 1.28e-03 |
| ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 1.47e-02 | -0.245000 | 7.19e-02 |
| PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 1.00e-01 | -0.245000 | 2.57e-01 |
| VOLTAGE GATED POTASSIUM CHANNELS | 39 | 8.06e-03 | 0.245000 | 4.50e-02 |
| ERKS ARE INACTIVATED | 13 | 1.26e-01 | -0.245000 | 2.97e-01 |
| REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 1.01e-01 | 0.245000 | 2.57e-01 |
| ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 1.80e-01 | -0.245000 | 3.76e-01 |
| ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 63 | 7.99e-04 | -0.244000 | 7.00e-03 |
| ANCHORING FIBRIL FORMATION | 14 | 1.16e-01 | 0.243000 | 2.81e-01 |
| METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 1.04e-01 | -0.243000 | 2.62e-01 |
| DUAL INCISION IN TC NER | 64 | 8.02e-04 | -0.242000 | 7.00e-03 |
| C TYPE LECTIN RECEPTORS CLRS | 116 | 6.82e-06 | -0.242000 | 1.18e-04 |
| CITRIC ACID CYCLE TCA CYCLE | 22 | 4.96e-02 | -0.242000 | 1.63e-01 |
| GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 4.04e-02 | -0.242000 | 1.43e-01 |
| CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 5.16e-03 | -0.241000 | 3.20e-02 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 6.31e-02 | 0.240000 | 1.91e-01 |
| TNFR2 NON CANONICAL NF KB PATHWAY | 82 | 1.80e-04 | -0.239000 | 1.92e-03 |
| CONDENSATION OF PROPHASE CHROMOSOMES | 29 | 2.60e-02 | -0.239000 | 1.07e-01 |
| TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 2.98e-04 | -0.238000 | 3.01e-03 |
| SIGNALING BY NTRK3 TRKC | 17 | 8.94e-02 | 0.238000 | 2.42e-01 |
| MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 1.41e-01 | -0.236000 | 3.20e-01 |
| PEROXISOMAL PROTEIN IMPORT | 58 | 1.92e-03 | -0.236000 | 1.45e-02 |
| INHIBITION OF DNA RECOMBINATION AT TELOMERE | 36 | 1.45e-02 | -0.236000 | 7.11e-02 |
| PHASE 0 RAPID DEPOLARISATION | 28 | 3.22e-02 | 0.234000 | 1.22e-01 |
| BILE ACID AND BILE SALT METABOLISM | 25 | 4.31e-02 | 0.234000 | 1.49e-01 |
| SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.62e-01 | -0.233000 | 3.51e-01 |
| SIGNALING BY THE B CELL RECEPTOR BCR | 104 | 4.22e-05 | -0.232000 | 5.72e-04 |
| TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 2.03e-01 | -0.232000 | 4.07e-01 |
| CDC42 GTPASE CYCLE | 154 | 6.78e-07 | 0.232000 | 1.99e-05 |
| FGFR1 LIGAND BINDING AND ACTIVATION | 10 | 2.05e-01 | -0.232000 | 4.07e-01 |
| HIV INFECTION | 222 | 2.88e-09 | -0.231000 | 2.00e-07 |
| SEPARATION OF SISTER CHROMATIDS | 166 | 2.71e-07 | -0.231000 | 9.40e-06 |
| ECM PROTEOGLYCANS | 66 | 1.17e-03 | 0.231000 | 9.48e-03 |
| TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 8.97e-02 | -0.231000 | 2.43e-01 |
| FERTILIZATION | 13 | 1.50e-01 | 0.231000 | 3.34e-01 |
| THE NLRP3 INFLAMMASOME | 14 | 1.36e-01 | -0.230000 | 3.14e-01 |
| TRIGLYCERIDE METABOLISM | 24 | 5.21e-02 | -0.229000 | 1.68e-01 |
| INTERFERON GAMMA SIGNALING | 79 | 4.36e-04 | -0.229000 | 4.21e-03 |
| SIGNALING BY NOTCH4 | 83 | 3.47e-04 | -0.227000 | 3.41e-03 |
| MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 6.00e-02 | -0.227000 | 1.84e-01 |
| TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 38 | 1.57e-02 | -0.227000 | 7.54e-02 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 9.65e-02 | 0.226000 | 2.51e-01 |
| MAPK6 MAPK4 SIGNALING | 85 | 3.14e-04 | -0.226000 | 3.11e-03 |
| CELLULAR RESPONSE TO CHEMICAL STRESS | 152 | 1.77e-06 | -0.225000 | 4.18e-05 |
| STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 2.20e-01 | 0.224000 | 4.25e-01 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 7.62e-02 | -0.224000 | 2.19e-01 |
| RIPK1 MEDIATED REGULATED NECROSIS | 25 | 5.37e-02 | -0.223000 | 1.71e-01 |
| SIGNALING BY FGFR2 IN DISEASE | 37 | 1.92e-02 | -0.222000 | 8.63e-02 |
| METALLOPROTEASE DUBS | 25 | 5.44e-02 | -0.222000 | 1.73e-01 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 6.61e-02 | 0.221000 | 1.96e-01 |
| CYTOPROTECTION BY HMOX1 | 119 | 3.13e-05 | -0.221000 | 4.39e-04 |
| NONSENSE MEDIATED DECAY NMD | 110 | 6.31e-05 | -0.221000 | 8.09e-04 |
| MISMATCH REPAIR | 14 | 1.53e-01 | -0.221000 | 3.36e-01 |
| GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 5.16e-02 | -0.221000 | 1.67e-01 |
| INFLUENZA INFECTION | 146 | 4.88e-06 | -0.219000 | 9.06e-05 |
| MITOTIC METAPHASE AND ANAPHASE | 208 | 5.59e-08 | -0.219000 | 2.53e-06 |
| DISEASES OF MITOTIC CELL CYCLE | 37 | 2.15e-02 | -0.218000 | 9.36e-02 |
| ASPARTATE AND ASPARAGINE METABOLISM | 11 | 2.10e-01 | -0.218000 | 4.11e-01 |
| NICOTINAMIDE SALVAGING | 15 | 1.44e-01 | -0.218000 | 3.24e-01 |
| CHOLESTEROL BIOSYNTHESIS | 24 | 6.59e-02 | -0.217000 | 1.96e-01 |
| NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 2.35e-01 | 0.217000 | 4.44e-01 |
| NCAM1 INTERACTIONS | 41 | 1.63e-02 | 0.217000 | 7.76e-02 |
| METABOLISM OF AMINO ACIDS AND DERIVATIVES | 320 | 2.92e-11 | -0.217000 | 4.92e-09 |
| NUCLEOTIDE EXCISION REPAIR | 109 | 1.02e-04 | -0.216000 | 1.21e-03 |
| OLFACTORY SIGNALING PATHWAY | 33 | 3.28e-02 | 0.215000 | 1.23e-01 |
| BLOOD GROUP SYSTEMS BIOSYNTHESIS | 14 | 1.67e-01 | -0.214000 | 3.59e-01 |
| SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 25 | 6.46e-02 | -0.214000 | 1.94e-01 |
| ION TRANSPORT BY P TYPE ATPASES | 51 | 8.42e-03 | 0.213000 | 4.64e-02 |
| EFFECTS OF PIP2 HYDROLYSIS | 27 | 5.55e-02 | 0.213000 | 1.76e-01 |
| NEPHRIN FAMILY INTERACTIONS | 23 | 7.72e-02 | 0.213000 | 2.20e-01 |
| GLYCOGEN SYNTHESIS | 14 | 1.70e-01 | -0.212000 | 3.61e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 8.54e-02 | 0.212000 | 2.37e-01 |
| CELL CYCLE CHECKPOINTS | 244 | 1.32e-08 | -0.211000 | 7.41e-07 |
| BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 1.45e-03 | -0.211000 | 1.15e-02 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 2.05e-01 | -0.211000 | 4.07e-01 |
| SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 1.88e-01 | -0.211000 | 3.85e-01 |
| ERK MAPK TARGETS | 22 | 8.71e-02 | -0.211000 | 2.39e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 1.74e-01 | 0.210000 | 3.67e-01 |
| FC EPSILON RECEPTOR FCERI SIGNALING | 124 | 5.57e-05 | -0.210000 | 7.30e-04 |
| PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 1.14e-01 | 0.210000 | 2.79e-01 |
| ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 1.75e-02 | 0.209000 | 8.17e-02 |
| HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 2.20e-02 | -0.209000 | 9.45e-02 |
| PRE NOTCH PROCESSING IN GOLGI | 18 | 1.25e-01 | 0.209000 | 2.96e-01 |
| INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 9.02e-02 | -0.209000 | 2.43e-01 |
| G PROTEIN BETA GAMMA SIGNALLING | 31 | 4.49e-02 | -0.208000 | 1.54e-01 |
| RRNA PROCESSING | 195 | 5.69e-07 | -0.208000 | 1.72e-05 |
| TCR SIGNALING | 102 | 2.96e-04 | -0.207000 | 3.01e-03 |
| DEPOLYMERISATION OF THE NUCLEAR LAMINA | 14 | 1.82e-01 | -0.206000 | 3.77e-01 |
| APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 1.30e-01 | -0.206000 | 3.03e-01 |
| DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 2.61e-02 | 0.206000 | 1.07e-01 |
| NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 1.43e-01 | -0.205000 | 3.22e-01 |
| SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 5.26e-03 | -0.205000 | 3.21e-02 |
| METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 2.62e-01 | -0.205000 | 4.75e-01 |
| ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 9.80e-02 | 0.204000 | 2.54e-01 |
| SHC MEDIATED CASCADE FGFR1 | 16 | 1.58e-01 | -0.204000 | 3.46e-01 |
| G0 AND EARLY G1 | 25 | 7.80e-02 | -0.204000 | 2.21e-01 |
| INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 18 | 1.38e-01 | -0.202000 | 3.16e-01 |
| DUAL INCISION IN GG NER | 40 | 2.74e-02 | -0.202000 | 1.10e-01 |
| INTERLEUKIN 2 FAMILY SIGNALING | 32 | 4.88e-02 | 0.201000 | 1.61e-01 |
| COPII MEDIATED VESICLE TRANSPORT | 66 | 4.83e-03 | -0.201000 | 3.08e-02 |
| SARS COV 1 INFECTION | 48 | 1.68e-02 | -0.199000 | 7.93e-02 |
| NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 2.54e-01 | 0.199000 | 4.66e-01 |
| INTERLEUKIN 1 SIGNALING | 96 | 8.60e-04 | -0.197000 | 7.40e-03 |
| CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 1.90e-02 | 0.196000 | 8.57e-02 |
| INOSITOL PHOSPHATE METABOLISM | 46 | 2.20e-02 | 0.195000 | 9.45e-02 |
| FCERI MEDIATED MAPK ACTIVATION | 28 | 7.38e-02 | -0.195000 | 2.14e-01 |
| UCH PROTEINASES | 90 | 1.38e-03 | -0.195000 | 1.10e-02 |
| TRANSCRIPTION OF THE HIV GENOME | 67 | 5.96e-03 | -0.194000 | 3.58e-02 |
| FATTY ACID METABOLISM | 146 | 5.12e-05 | -0.194000 | 6.78e-04 |
| NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 66 | 6.36e-03 | -0.194000 | 3.77e-02 |
| ABC TRANSPORTER DISORDERS | 71 | 4.70e-03 | -0.194000 | 3.03e-02 |
| SIGNALING BY ROBO RECEPTORS | 210 | 1.31e-06 | -0.194000 | 3.43e-05 |
| PROGRAMMED CELL DEATH | 188 | 5.07e-06 | -0.193000 | 9.06e-05 |
| MTORC1 MEDIATED SIGNALLING | 24 | 1.02e-01 | -0.193000 | 2.59e-01 |
| EXTRA NUCLEAR ESTROGEN SIGNALING | 68 | 6.05e-03 | -0.193000 | 3.62e-02 |
| REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 2.93e-01 | 0.192000 | 5.10e-01 |
| DNA DAMAGE RECOGNITION IN GG NER | 38 | 4.06e-02 | -0.192000 | 1.43e-01 |
| CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 1.59e-01 | 0.192000 | 3.46e-01 |
| RAF ACTIVATION | 34 | 5.30e-02 | -0.192000 | 1.70e-01 |
| PKMTS METHYLATE HISTONE LYSINES | 49 | 2.10e-02 | 0.191000 | 9.24e-02 |
| SIALIC ACID METABOLISM | 32 | 6.29e-02 | -0.190000 | 1.91e-01 |
| FATTY ACYL COA BIOSYNTHESIS | 32 | 6.32e-02 | -0.190000 | 1.91e-01 |
| PEROXISOMAL LIPID METABOLISM | 26 | 9.40e-02 | -0.190000 | 2.47e-01 |
| INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 2.36e-01 | -0.190000 | 4.46e-01 |
| IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 2.77e-01 | 0.189000 | 4.92e-01 |
| PIWI INTERACTING RNA PIRNA BIOGENESIS | 19 | 1.53e-01 | -0.189000 | 3.37e-01 |
| ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 3.02e-01 | 0.189000 | 5.19e-01 |
| INTERFERON SIGNALING | 167 | 2.75e-05 | -0.188000 | 3.95e-04 |
| ANTIMICROBIAL PEPTIDES | 17 | 1.79e-01 | -0.188000 | 3.75e-01 |
| MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 2.07e-01 | -0.188000 | 4.09e-01 |
| COSTIMULATION BY THE CD28 FAMILY | 50 | 2.15e-02 | -0.188000 | 9.36e-02 |
| CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 23 | 1.22e-01 | -0.186000 | 2.94e-01 |
| RHOA GTPASE CYCLE | 143 | 1.25e-04 | 0.186000 | 1.41e-03 |
| RUNX2 REGULATES BONE DEVELOPMENT | 29 | 8.47e-02 | 0.185000 | 2.36e-01 |
| ARACHIDONIC ACID METABOLISM | 40 | 4.34e-02 | -0.185000 | 1.50e-01 |
| IRE1ALPHA ACTIVATES CHAPERONES | 50 | 2.40e-02 | 0.185000 | 1.01e-01 |
| PCP CE PATHWAY | 90 | 2.53e-03 | -0.184000 | 1.83e-02 |
| INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 1.19e-01 | -0.184000 | 2.87e-01 |
| N GLYCAN ANTENNAE ELONGATION | 15 | 2.18e-01 | -0.184000 | 4.22e-01 |
| DAG AND IP3 SIGNALING | 40 | 4.48e-02 | 0.183000 | 1.54e-01 |
| REGULATION OF GENE EXPRESSION IN BETA CELLS | 12 | 2.71e-01 | -0.183000 | 4.86e-01 |
| NUCLEOBASE BIOSYNTHESIS | 15 | 2.21e-01 | -0.182000 | 4.26e-01 |
| RND2 GTPASE CYCLE | 39 | 4.99e-02 | 0.182000 | 1.64e-01 |
| G2 M DNA DAMAGE CHECKPOINT | 67 | 1.04e-02 | -0.181000 | 5.55e-02 |
| SARS COV 2 INFECTION | 65 | 1.17e-02 | -0.181000 | 6.11e-02 |
| SEMA4D IN SEMAPHORIN SIGNALING | 24 | 1.26e-01 | 0.181000 | 2.97e-01 |
| INTERLEUKIN 20 FAMILY SIGNALING | 14 | 2.42e-01 | 0.180000 | 4.53e-01 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 2.60e-01 | 0.180000 | 4.74e-01 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 1.35e-01 | -0.180000 | 3.11e-01 |
| SYNTHESIS OF PA | 29 | 9.33e-02 | 0.180000 | 2.46e-01 |
| APOPTOSIS | 166 | 6.55e-05 | -0.180000 | 8.30e-04 |
| BIOLOGICAL OXIDATIONS | 125 | 5.38e-04 | -0.179000 | 4.96e-03 |
| SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 2.29e-01 | -0.179000 | 4.36e-01 |
| DISEASES OF PROGRAMMED CELL DEATH | 55 | 2.17e-02 | -0.179000 | 9.39e-02 |
| ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 2.47e-01 | 0.179000 | 4.58e-01 |
| LAMININ INTERACTIONS | 28 | 1.03e-01 | 0.178000 | 2.61e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 9.20e-02 | 0.178000 | 2.45e-01 |
| RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 8.76e-02 | -0.177000 | 2.40e-01 |
| G1 S SPECIFIC TRANSCRIPTION | 27 | 1.11e-01 | -0.177000 | 2.74e-01 |
| CHROMOSOME MAINTENANCE | 102 | 2.03e-03 | -0.177000 | 1.52e-02 |
| PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 2.72e-01 | -0.176000 | 4.86e-01 |
| CHAPERONE MEDIATED AUTOPHAGY | 21 | 1.65e-01 | -0.175000 | 3.57e-01 |
| RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 23 | 1.46e-01 | -0.175000 | 3.27e-01 |
| AMINO ACIDS REGULATE MTORC1 | 51 | 3.10e-02 | -0.175000 | 1.20e-01 |
| NCAM SIGNALING FOR NEURITE OUT GROWTH | 61 | 1.86e-02 | 0.174000 | 8.47e-02 |
| TRAFFICKING OF AMPA RECEPTORS | 31 | 9.36e-02 | 0.174000 | 2.46e-01 |
| DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 38 | 6.38e-02 | -0.174000 | 1.92e-01 |
| CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 14 | 2.61e-01 | -0.174000 | 4.74e-01 |
| ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 9.02e-02 | 0.173000 | 2.43e-01 |
| HIV LIFE CYCLE | 142 | 3.78e-04 | -0.173000 | 3.68e-03 |
| CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 3.00e-01 | 0.173000 | 5.19e-01 |
| SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 2.05e-01 | 0.173000 | 4.07e-01 |
| MITOTIC PROPHASE | 96 | 3.56e-03 | -0.172000 | 2.37e-02 |
| TELOMERE MAINTENANCE | 79 | 8.20e-03 | -0.172000 | 4.54e-02 |
| TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 1.09e-01 | 0.172000 | 2.70e-01 |
| TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 18 | 2.07e-01 | 0.172000 | 4.09e-01 |
| TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 1.84e-01 | -0.172000 | 3.80e-01 |
| SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 5.78e-02 | 0.171000 | 1.80e-01 |
| MET PROMOTES CELL MOTILITY | 38 | 6.80e-02 | 0.171000 | 2.00e-01 |
| NEDDYLATION | 221 | 1.21e-05 | -0.171000 | 1.88e-04 |
| REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 3.50e-01 | -0.171000 | 5.66e-01 |
| BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 2.38e-01 | -0.171000 | 4.47e-01 |
| SEMAPHORIN INTERACTIONS | 64 | 1.85e-02 | 0.170000 | 8.47e-02 |
| RHO GTPASES ACTIVATE KTN1 | 11 | 3.30e-01 | -0.169000 | 5.44e-01 |
| LATE ENDOSOMAL MICROAUTOPHAGY | 32 | 9.81e-02 | -0.169000 | 2.54e-01 |
| GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 1.09e-01 | -0.169000 | 2.70e-01 |
| ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 2.15e-01 | 0.169000 | 4.18e-01 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 2.92e-01 | -0.169000 | 5.10e-01 |
| NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 8.91e-02 | -0.169000 | 2.42e-01 |
| CARGO CONCENTRATION IN THE ER | 31 | 1.05e-01 | -0.168000 | 2.65e-01 |
| MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 2.17e-01 | 0.168000 | 4.20e-01 |
| CROSSLINKING OF COLLAGEN FIBRILS | 16 | 2.45e-01 | 0.168000 | 4.57e-01 |
| DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 1.39e-01 | -0.168000 | 3.18e-01 |
| CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 3.16e-01 | 0.167000 | 5.31e-01 |
| CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 3.38e-01 | -0.167000 | 5.52e-01 |
| GLUCAGON TYPE LIGAND RECEPTORS | 26 | 1.41e-01 | -0.167000 | 3.20e-01 |
| FGFRL1 MODULATION OF FGFR1 SIGNALING | 10 | 3.61e-01 | -0.167000 | 5.73e-01 |
| RAC1 GTPASE CYCLE | 179 | 1.22e-04 | 0.167000 | 1.40e-03 |
| INFLAMMASOMES | 18 | 2.21e-01 | -0.167000 | 4.26e-01 |
| SHC1 EVENTS IN EGFR SIGNALING | 11 | 3.40e-01 | -0.166000 | 5.54e-01 |
| MITOTIC SPINDLE CHECKPOINT | 96 | 4.99e-03 | -0.166000 | 3.15e-02 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 3.01e-01 | 0.166000 | 5.19e-01 |
| INITIAL TRIGGERING OF COMPLEMENT | 13 | 3.05e-01 | 0.164000 | 5.21e-01 |
| PI 3K CASCADE FGFR2 | 17 | 2.41e-01 | -0.164000 | 4.51e-01 |
| GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 3.53e-02 | -0.164000 | 1.29e-01 |
| FGFR2 LIGAND BINDING AND ACTIVATION | 13 | 3.06e-01 | -0.164000 | 5.22e-01 |
| G ALPHA 12 13 SIGNALLING EVENTS | 75 | 1.41e-02 | 0.164000 | 7.01e-02 |
| CD28 CO STIMULATION | 31 | 1.15e-01 | -0.164000 | 2.79e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX2 | 110 | 3.08e-03 | -0.163000 | 2.10e-02 |
| RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 1.66e-01 | -0.163000 | 3.59e-01 |
| ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 1.96e-01 | -0.163000 | 3.98e-01 |
| DEADENYLATION OF MRNA | 25 | 1.59e-01 | -0.163000 | 3.46e-01 |
| DAP12 INTERACTIONS | 30 | 1.23e-01 | -0.163000 | 2.94e-01 |
| FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 1.06e-01 | -0.163000 | 2.65e-01 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 64 | 2.53e-02 | 0.162000 | 1.05e-01 |
| CYTOSOLIC TRNA AMINOACYLATION | 24 | 1.71e-01 | -0.162000 | 3.62e-01 |
| TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 3.54e-01 | -0.161000 | 5.69e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 3.14e-01 | 0.161000 | 5.31e-01 |
| HDMS DEMETHYLATE HISTONES | 28 | 1.41e-01 | 0.161000 | 3.20e-01 |
| TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 87 | 9.70e-03 | 0.160000 | 5.25e-02 |
| SIGNALING BY INSULIN RECEPTOR | 64 | 2.66e-02 | -0.160000 | 1.08e-01 |
| NUCLEAR ENVELOPE NE REASSEMBLY | 65 | 2.55e-02 | -0.160000 | 1.06e-01 |
| TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 3.21e-02 | 0.160000 | 1.22e-01 |
| SCAVENGING OF HEME FROM PLASMA | 11 | 3.59e-01 | -0.160000 | 5.70e-01 |
| CTLA4 INHIBITORY SIGNALING | 20 | 2.17e-01 | -0.160000 | 4.20e-01 |
| SENSORY PROCESSING OF SOUND | 61 | 3.17e-02 | 0.159000 | 1.22e-01 |
| RND3 GTPASE CYCLE | 38 | 9.17e-02 | 0.158000 | 2.45e-01 |
| UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 2.10e-01 | 0.158000 | 4.11e-01 |
| SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 3.65e-01 | -0.158000 | 5.76e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 9.71e-02 | -0.158000 | 2.52e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 2.47e-01 | 0.158000 | 4.59e-01 |
| SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 8.14e-02 | -0.157000 | 2.29e-01 |
| P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 3.46e-01 | 0.157000 | 5.60e-01 |
| SPHINGOLIPID METABOLISM | 79 | 1.62e-02 | -0.156000 | 7.75e-02 |
| CELL CYCLE MITOTIC | 476 | 5.41e-09 | -0.156000 | 3.36e-07 |
| PI 3K CASCADE FGFR1 | 16 | 2.80e-01 | -0.156000 | 4.96e-01 |
| DISEASES OF GLYCOSYLATION | 126 | 2.49e-03 | 0.156000 | 1.81e-02 |
| ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 1.05e-01 | 0.156000 | 2.65e-01 |
| STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 3.15e-01 | 0.155000 | 5.31e-01 |
| BASE EXCISION REPAIR | 57 | 4.29e-02 | -0.155000 | 1.49e-01 |
| NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 2.69e-01 | 0.155000 | 4.83e-01 |
| GLYCOSPHINGOLIPID METABOLISM | 38 | 9.86e-02 | -0.155000 | 2.54e-01 |
| DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 2.71e-01 | -0.154000 | 4.86e-01 |
| G PROTEIN MEDIATED EVENTS | 51 | 5.75e-02 | 0.154000 | 1.79e-01 |
| PLATELET SENSITIZATION BY LDL | 15 | 3.03e-01 | -0.154000 | 5.20e-01 |
| NEUTROPHIL DEGRANULATION | 393 | 1.82e-07 | -0.154000 | 6.71e-06 |
| FRS MEDIATED FGFR2 SIGNALING | 19 | 2.47e-01 | -0.154000 | 4.58e-01 |
| METABOLISM OF RNA | 646 | 3.85e-11 | -0.153000 | 5.68e-09 |
| HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 62 | 3.82e-02 | -0.152000 | 1.37e-01 |
| SYNTHESIS OF PE | 13 | 3.42e-01 | 0.152000 | 5.57e-01 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 3.83e-01 | -0.152000 | 5.94e-01 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 3.43e-01 | -0.152000 | 5.57e-01 |
| N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 1.98e-01 | -0.152000 | 4.02e-01 |
| GPVI MEDIATED ACTIVATION CASCADE | 31 | 1.45e-01 | -0.151000 | 3.24e-01 |
| FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 119 | 4.49e-03 | 0.151000 | 2.92e-02 |
| ABC FAMILY PROTEINS MEDIATED TRANSPORT | 96 | 1.07e-02 | -0.151000 | 5.70e-02 |
| M PHASE | 342 | 1.75e-06 | -0.151000 | 4.18e-05 |
| RHOBTB2 GTPASE CYCLE | 23 | 2.11e-01 | -0.151000 | 4.12e-01 |
| THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 1.76e-01 | -0.150000 | 3.69e-01 |
| CELLULAR RESPONSES TO EXTERNAL STIMULI | 607 | 3.18e-10 | -0.150000 | 2.88e-08 |
| METABOLISM OF NUCLEOTIDES | 92 | 1.30e-02 | -0.150000 | 6.52e-02 |
| FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 1.42e-01 | 0.150000 | 3.22e-01 |
| INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 3.15e-01 | -0.150000 | 5.31e-01 |
| MUCOPOLYSACCHARIDOSES | 11 | 3.91e-01 | 0.150000 | 6.00e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 1.72e-01 | -0.149000 | 3.64e-01 |
| HIV TRANSCRIPTION ELONGATION | 42 | 9.51e-02 | -0.149000 | 2.49e-01 |
| PRE NOTCH EXPRESSION AND PROCESSING | 65 | 3.80e-02 | 0.149000 | 1.37e-01 |
| GAP JUNCTION ASSEMBLY | 21 | 2.39e-01 | -0.148000 | 4.49e-01 |
| DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 3.58e-01 | 0.147000 | 5.70e-01 |
| NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 9.88e-02 | -0.147000 | 2.54e-01 |
| TRNA PROCESSING IN THE NUCLEUS | 56 | 5.69e-02 | -0.147000 | 1.78e-01 |
| NICOTINATE METABOLISM | 25 | 2.03e-01 | -0.147000 | 4.07e-01 |
| RA BIOSYNTHESIS PATHWAY | 15 | 3.25e-01 | -0.147000 | 5.38e-01 |
| HSF1 ACTIVATION | 26 | 1.95e-01 | -0.147000 | 3.98e-01 |
| GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 3.10e-01 | -0.146000 | 5.26e-01 |
| PURINE SALVAGE | 12 | 3.81e-01 | -0.146000 | 5.93e-01 |
| CHROMATIN MODIFYING ENZYMES | 221 | 1.86e-04 | 0.146000 | 1.96e-03 |
| FRS MEDIATED FGFR1 SIGNALING | 18 | 2.84e-01 | -0.146000 | 5.01e-01 |
| CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 352 | 3.01e-06 | -0.145000 | 6.56e-05 |
| RMTS METHYLATE HISTONE ARGININES | 44 | 9.59e-02 | 0.145000 | 2.50e-01 |
| RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 1.27e-01 | 0.145000 | 3.00e-01 |
| FLT3 SIGNALING IN DISEASE | 28 | 1.88e-01 | 0.144000 | 3.85e-01 |
| REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 3.35e-01 | -0.144000 | 5.51e-01 |
| DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 2.91e-01 | -0.144000 | 5.08e-01 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 16 | 3.20e-01 | -0.144000 | 5.33e-01 |
| HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 8.64e-02 | -0.143000 | 2.38e-01 |
| INTERLEUKIN 6 FAMILY SIGNALING | 20 | 2.69e-01 | 0.143000 | 4.83e-01 |
| RET SIGNALING | 37 | 1.33e-01 | 0.143000 | 3.08e-01 |
| SIGNALING BY FGFR4 IN DISEASE | 11 | 4.14e-01 | -0.142000 | 6.24e-01 |
| CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 73 | 3.58e-02 | 0.142000 | 1.30e-01 |
| REGULATION OF IFNG SIGNALING | 13 | 3.76e-01 | -0.142000 | 5.89e-01 |
| ASPARAGINE N LINKED GLYCOSYLATION | 285 | 3.97e-05 | -0.142000 | 5.50e-04 |
| COLLAGEN FORMATION | 81 | 2.83e-02 | 0.141000 | 1.13e-01 |
| CELL CYCLE | 594 | 5.02e-09 | -0.141000 | 3.29e-07 |
| NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 2.64e-01 | 0.141000 | 4.78e-01 |
| TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 1.07e-01 | -0.141000 | 2.65e-01 |
| NEUROTRANSMITTER RELEASE CYCLE | 49 | 8.89e-02 | 0.141000 | 2.42e-01 |
| ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 17 | 3.18e-01 | 0.140000 | 5.31e-01 |
| RESOLUTION OF ABASIC SITES AP SITES | 37 | 1.43e-01 | -0.139000 | 3.22e-01 |
| IRAK4 DEFICIENCY TLR2 4 | 15 | 3.53e-01 | -0.139000 | 5.68e-01 |
| SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 3.56e-01 | 0.138000 | 5.69e-01 |
| TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 4.67e-02 | -0.138000 | 1.57e-01 |
| ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 3.28e-01 | -0.137000 | 5.40e-01 |
| REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 7.71e-02 | 0.137000 | 2.20e-01 |
| TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 32 | 1.81e-01 | -0.137000 | 3.77e-01 |
| ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 3.76e-01 | -0.137000 | 5.89e-01 |
| COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 1.17e-01 | -0.136000 | 2.85e-01 |
| RNA POLYMERASE I TRANSCRIPTION | 68 | 5.23e-02 | -0.136000 | 1.68e-01 |
| LONG TERM POTENTIATION | 23 | 2.59e-01 | 0.136000 | 4.74e-01 |
| HCMV LATE EVENTS | 66 | 5.64e-02 | -0.136000 | 1.78e-01 |
| EXTENSION OF TELOMERES | 49 | 1.01e-01 | -0.135000 | 2.57e-01 |
| CD209 DC SIGN SIGNALING | 18 | 3.22e-01 | -0.135000 | 5.34e-01 |
| RHOV GTPASE CYCLE | 33 | 1.80e-01 | 0.135000 | 3.76e-01 |
| BIOTIN TRANSPORT AND METABOLISM | 11 | 4.39e-01 | 0.135000 | 6.50e-01 |
| PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 12 | 4.19e-01 | -0.135000 | 6.30e-01 |
| RESOLUTION OF SISTER CHROMATID COHESION | 102 | 1.90e-02 | -0.135000 | 8.57e-02 |
| RHOU GTPASE CYCLE | 34 | 1.75e-01 | 0.134000 | 3.68e-01 |
| MRNA SPLICING MINOR PATHWAY | 52 | 9.37e-02 | -0.134000 | 2.46e-01 |
| ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 2.11e-01 | -0.134000 | 4.12e-01 |
| INNATE IMMUNE SYSTEM | 792 | 1.73e-10 | -0.134000 | 1.85e-08 |
| INFECTIOUS DISEASE | 737 | 7.05e-10 | -0.134000 | 5.54e-08 |
| NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 2.68e-01 | 0.133000 | 4.83e-01 |
| PROTEIN FOLDING | 89 | 2.99e-02 | -0.133000 | 1.17e-01 |
| ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 4.79e-02 | -0.133000 | 1.59e-01 |
| INTEGRIN SIGNALING | 24 | 2.59e-01 | 0.133000 | 4.74e-01 |
| PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 5.35e-02 | -0.133000 | 1.71e-01 |
| TP53 REGULATES METABOLIC GENES | 87 | 3.35e-02 | -0.132000 | 1.25e-01 |
| ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 290 | 1.17e-04 | -0.132000 | 1.35e-03 |
| PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 20 | 3.08e-01 | -0.132000 | 5.24e-01 |
| DEADENYLATION DEPENDENT MRNA DECAY | 55 | 9.13e-02 | -0.132000 | 2.45e-01 |
| EPHB MEDIATED FORWARD SIGNALING | 42 | 1.41e-01 | -0.131000 | 3.20e-01 |
| NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 4.13e-01 | -0.131000 | 6.23e-01 |
| SUMOYLATION OF TRANSCRIPTION FACTORS | 18 | 3.36e-01 | -0.131000 | 5.51e-01 |
| BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 2.48e-01 | 0.131000 | 4.59e-01 |
| PROLONGED ERK ACTIVATION EVENTS | 14 | 3.97e-01 | -0.131000 | 6.09e-01 |
| AMYLOID FIBER FORMATION | 58 | 8.54e-02 | -0.131000 | 2.37e-01 |
| TOLL LIKE RECEPTOR CASCADES | 141 | 7.48e-03 | -0.131000 | 4.24e-02 |
| ONCOGENE INDUCED SENESCENCE | 32 | 2.02e-01 | 0.130000 | 4.07e-01 |
| ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 2.28e-01 | -0.129000 | 4.35e-01 |
| INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 1.52e-01 | 0.129000 | 3.36e-01 |
| STIMULI SENSING CHANNELS | 76 | 5.15e-02 | 0.129000 | 1.67e-01 |
| TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 4.41e-01 | 0.129000 | 6.51e-01 |
| ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 4.82e-01 | 0.129000 | 6.87e-01 |
| HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 4.82e-01 | 0.129000 | 6.87e-01 |
| DEGRADATION OF THE EXTRACELLULAR MATRIX | 108 | 2.13e-02 | 0.128000 | 9.34e-02 |
| PLATELET CALCIUM HOMEOSTASIS | 26 | 2.60e-01 | 0.128000 | 4.74e-01 |
| METABOLISM OF FAT SOLUBLE VITAMINS | 33 | 2.05e-01 | 0.127000 | 4.07e-01 |
| MEIOTIC RECOMBINATION | 39 | 1.69e-01 | -0.127000 | 3.61e-01 |
| CYTOKINE SIGNALING IN IMMUNE SYSTEM | 553 | 3.83e-07 | -0.127000 | 1.25e-05 |
| NON INTEGRIN MEMBRANE ECM INTERACTIONS | 56 | 1.01e-01 | 0.127000 | 2.57e-01 |
| FOXO MEDIATED TRANSCRIPTION | 59 | 9.28e-02 | -0.127000 | 2.46e-01 |
| L1CAM INTERACTIONS | 107 | 2.39e-02 | 0.126000 | 1.01e-01 |
| REGULATION OF TNFR1 SIGNALING | 34 | 2.02e-01 | 0.126000 | 4.07e-01 |
| RHO GTPASES ACTIVATE NADPH OXIDASES | 22 | 3.07e-01 | -0.126000 | 5.23e-01 |
| SNRNP ASSEMBLY | 51 | 1.20e-01 | -0.126000 | 2.90e-01 |
| EXTRACELLULAR MATRIX ORGANIZATION | 247 | 6.90e-04 | 0.126000 | 6.21e-03 |
| LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 4.34e-01 | 0.125000 | 6.45e-01 |
| PEXOPHAGY | 11 | 4.73e-01 | 0.125000 | 6.82e-01 |
| ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 22 | 3.11e-01 | -0.125000 | 5.26e-01 |
| METABOLISM OF AMINE DERIVED HORMONES | 10 | 4.95e-01 | 0.125000 | 6.96e-01 |
| NEGATIVE REGULATION OF FGFR2 SIGNALING | 28 | 2.54e-01 | -0.125000 | 4.66e-01 |
| B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 48 | 1.36e-01 | -0.125000 | 3.13e-01 |
| RHO GTPASES ACTIVATE IQGAPS | 24 | 2.91e-01 | -0.125000 | 5.08e-01 |
| EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 2.47e-01 | 0.124000 | 4.58e-01 |
| PRC2 METHYLATES HISTONES AND DNA | 30 | 2.40e-01 | -0.124000 | 4.49e-01 |
| HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 1.99e-01 | -0.124000 | 4.03e-01 |
| GLUCONEOGENESIS | 27 | 2.67e-01 | -0.124000 | 4.81e-01 |
| ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 14 | 4.24e-01 | 0.123000 | 6.34e-01 |
| AUTOPHAGY | 140 | 1.20e-02 | -0.123000 | 6.18e-02 |
| TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 171 | 5.58e-03 | -0.123000 | 3.39e-02 |
| INWARDLY RECTIFYING K CHANNELS | 32 | 2.31e-01 | -0.122000 | 4.37e-01 |
| SIGNALING BY FLT3 FUSION PROTEINS | 19 | 3.58e-01 | 0.122000 | 5.70e-01 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 5.06e-01 | -0.121000 | 7.02e-01 |
| SUMOYLATION OF INTRACELLULAR RECEPTORS | 26 | 2.84e-01 | -0.121000 | 5.01e-01 |
| METABOLISM OF STEROID HORMONES | 21 | 3.37e-01 | -0.121000 | 5.51e-01 |
| TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 179 | 5.24e-03 | -0.121000 | 3.21e-02 |
| RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 3.39e-01 | -0.121000 | 5.52e-01 |
| SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 64 | 9.55e-02 | -0.121000 | 2.50e-01 |
| RHO GTPASES ACTIVATE PKNS | 48 | 1.51e-01 | -0.120000 | 3.35e-01 |
| TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 2.73e-01 | -0.120000 | 4.86e-01 |
| TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 1.28e-01 | 0.120000 | 3.00e-01 |
| SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 7.78e-02 | -0.119000 | 2.21e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 4.56e-02 | -0.119000 | 1.54e-01 |
| P75NTR SIGNALS VIA NF KB | 16 | 4.09e-01 | 0.119000 | 6.20e-01 |
| RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 1.13e-01 | -0.119000 | 2.78e-01 |
| HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 53 | 1.34e-01 | 0.119000 | 3.11e-01 |
| WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 3.46e-01 | -0.119000 | 5.60e-01 |
| MITOTIC G2 G2 M PHASES | 187 | 5.12e-03 | -0.119000 | 3.19e-02 |
| MTOR SIGNALLING | 41 | 1.90e-01 | -0.118000 | 3.87e-01 |
| SIGNALING BY NOTCH1 | 75 | 7.64e-02 | 0.118000 | 2.19e-01 |
| NEGATIVE REGULATION OF FGFR1 SIGNALING | 27 | 2.87e-01 | -0.118000 | 5.05e-01 |
| SENSORY PERCEPTION | 153 | 1.20e-02 | 0.118000 | 6.18e-02 |
| POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 62 | 1.09e-01 | -0.118000 | 2.70e-01 |
| SIGNALING BY RETINOIC ACID | 35 | 2.28e-01 | -0.118000 | 4.35e-01 |
| INTERLEUKIN 17 SIGNALING | 68 | 9.34e-02 | -0.118000 | 2.46e-01 |
| INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 1.42e-01 | -0.118000 | 3.22e-01 |
| NEURONAL SYSTEM | 373 | 1.01e-04 | 0.117000 | 1.21e-03 |
| REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 4.82e-01 | -0.117000 | 6.87e-01 |
| INTERLEUKIN 1 FAMILY SIGNALING | 123 | 2.48e-02 | -0.117000 | 1.04e-01 |
| HEME SIGNALING | 46 | 1.69e-01 | 0.117000 | 3.61e-01 |
| REGULATION OF IFNA SIGNALING | 12 | 4.82e-01 | 0.117000 | 6.87e-01 |
| GENERATION OF SECOND MESSENGER MOLECULES | 19 | 3.79e-01 | -0.117000 | 5.92e-01 |
| RHO GTPASES ACTIVATE PAKS | 21 | 3.56e-01 | 0.116000 | 5.69e-01 |
| TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 2.55e-01 | -0.116000 | 4.67e-01 |
| INTERLEUKIN 10 SIGNALING | 19 | 3.81e-01 | -0.116000 | 5.93e-01 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 4.70e-01 | 0.116000 | 6.80e-01 |
| ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 5.28e-01 | 0.115000 | 7.22e-01 |
| NEGATIVE REGULATION OF FLT3 | 14 | 4.57e-01 | 0.115000 | 6.68e-01 |
| SIGNAL AMPLIFICATION | 30 | 2.80e-01 | -0.114000 | 4.96e-01 |
| DNA METHYLATION | 21 | 3.66e-01 | -0.114000 | 5.78e-01 |
| NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 3.68e-01 | -0.113000 | 5.79e-01 |
| RHO GTPASES ACTIVATE FORMINS | 118 | 3.36e-02 | -0.113000 | 1.25e-01 |
| NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 4.97e-01 | -0.113000 | 6.98e-01 |
| MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 2.68e-01 | 0.113000 | 4.83e-01 |
| TNF SIGNALING | 43 | 2.00e-01 | 0.113000 | 4.05e-01 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 5.00e-01 | 0.112000 | 7.00e-01 |
| MYD88 INDEPENDENT TLR4 CASCADE | 94 | 5.96e-02 | -0.112000 | 1.84e-01 |
| ER TO GOLGI ANTEROGRADE TRANSPORT | 142 | 2.09e-02 | -0.112000 | 9.24e-02 |
| RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.52e-01 | 0.112000 | 6.65e-01 |
| TBC RABGAPS | 43 | 2.04e-01 | -0.112000 | 4.07e-01 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 4.68e-01 | 0.112000 | 6.79e-01 |
| TIE2 SIGNALING | 17 | 4.24e-01 | -0.112000 | 6.34e-01 |
| DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 4.68e-01 | 0.112000 | 6.79e-01 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 4.25e-01 | 0.112000 | 6.34e-01 |
| GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 4.00e-01 | 0.112000 | 6.10e-01 |
| CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 2.83e-01 | 0.111000 | 5.00e-01 |
| O LINKED GLYCOSYLATION | 88 | 7.13e-02 | 0.111000 | 2.09e-01 |
| DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 3.17e-01 | 0.111000 | 5.31e-01 |
| G ALPHA Z SIGNALLING EVENTS | 44 | 2.04e-01 | -0.111000 | 4.07e-01 |
| ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 97 | 5.96e-02 | 0.111000 | 1.84e-01 |
| SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 4.89e-01 | -0.111000 | 6.93e-01 |
| COHESIN LOADING ONTO CHROMATIN | 10 | 5.45e-01 | -0.111000 | 7.38e-01 |
| ADAPTIVE IMMUNE SYSTEM | 614 | 3.69e-06 | -0.110000 | 7.78e-05 |
| ACYL CHAIN REMODELLING OF PS | 14 | 4.78e-01 | -0.110000 | 6.87e-01 |
| IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 53 | 1.68e-01 | -0.110000 | 3.60e-01 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 1230 | 1.90e-10 | -0.109000 | 1.87e-08 |
| GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 3.67e-01 | 0.109000 | 5.78e-01 |
| DNA REPAIR | 292 | 1.47e-03 | -0.108000 | 1.15e-02 |
| ASSEMBLY OF THE HIV VIRION | 16 | 4.55e-01 | -0.108000 | 6.67e-01 |
| LYSINE CATABOLISM | 11 | 5.37e-01 | 0.107000 | 7.32e-01 |
| INTEGRATION OF ENERGY METABOLISM | 99 | 6.50e-02 | 0.107000 | 1.94e-01 |
| KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 4.58e-01 | -0.107000 | 6.70e-01 |
| BETA CATENIN INDEPENDENT WNT SIGNALING | 140 | 2.89e-02 | -0.107000 | 1.15e-01 |
| ION HOMEOSTASIS | 51 | 1.87e-01 | 0.107000 | 3.84e-01 |
| GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 5.06e-01 | 0.107000 | 7.02e-01 |
| TRNA PROCESSING | 105 | 6.03e-02 | -0.106000 | 1.84e-01 |
| RHOH GTPASE CYCLE | 37 | 2.64e-01 | -0.106000 | 4.78e-01 |
| ION CHANNEL TRANSPORT | 144 | 2.83e-02 | 0.106000 | 1.13e-01 |
| PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 22 | 3.92e-01 | -0.105000 | 6.02e-01 |
| DISEASES OF METABOLISM | 200 | 1.10e-02 | 0.104000 | 5.81e-02 |
| TERMINATION OF O GLYCAN BIOSYNTHESIS | 11 | 5.50e-01 | 0.104000 | 7.40e-01 |
| BASE EXCISION REPAIR AP SITE FORMATION | 30 | 3.23e-01 | -0.104000 | 5.36e-01 |
| PEPTIDE HORMONE METABOLISM | 60 | 1.67e-01 | -0.103000 | 3.59e-01 |
| LYSOSOME VESICLE BIOGENESIS | 33 | 3.07e-01 | -0.103000 | 5.23e-01 |
| TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 64 | 1.55e-01 | -0.103000 | 3.39e-01 |
| FLT3 SIGNALING | 36 | 2.88e-01 | 0.102000 | 5.05e-01 |
| TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 13 | 5.23e-01 | 0.102000 | 7.16e-01 |
| SMOOTH MUSCLE CONTRACTION | 33 | 3.09e-01 | 0.102000 | 5.26e-01 |
| RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 4.30e-01 | 0.102000 | 6.39e-01 |
| GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 4.94e-01 | -0.102000 | 6.96e-01 |
| PLATELET AGGREGATION PLUG FORMATION | 32 | 3.19e-01 | 0.102000 | 5.32e-01 |
| AQUAPORIN MEDIATED TRANSPORT | 42 | 2.56e-01 | -0.101000 | 4.68e-01 |
| MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 4.22e-01 | 0.101000 | 6.32e-01 |
| DISEASES OF DNA REPAIR | 11 | 5.61e-01 | 0.101000 | 7.51e-01 |
| CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 2.25e-01 | -0.100000 | 4.30e-01 |
| UB SPECIFIC PROCESSING PROTEASES | 169 | 2.48e-02 | -0.100000 | 1.04e-01 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 21 | 4.27e-01 | -0.100000 | 6.36e-01 |
| HOMOLOGY DIRECTED REPAIR | 107 | 7.43e-02 | -0.099900 | 2.15e-01 |
| CA DEPENDENT EVENTS | 36 | 3.01e-01 | 0.099600 | 5.19e-01 |
| PTEN REGULATION | 136 | 4.56e-02 | -0.099400 | 1.54e-01 |
| NETRIN 1 SIGNALING | 50 | 2.25e-01 | 0.099300 | 4.30e-01 |
| COLLAGEN CHAIN TRIMERIZATION | 41 | 2.73e-01 | 0.099000 | 4.86e-01 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 4.80e-01 | -0.098900 | 6.87e-01 |
| PARASITE INFECTION | 54 | 2.10e-01 | -0.098600 | 4.11e-01 |
| HEDGEHOG ON STATE | 83 | 1.22e-01 | -0.098300 | 2.93e-01 |
| DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 1.74e-01 | -0.098300 | 3.67e-01 |
| SIGNALING BY INTERLEUKINS | 353 | 1.55e-03 | -0.098300 | 1.20e-02 |
| P38MAPK EVENTS | 13 | 5.41e-01 | -0.098000 | 7.35e-01 |
| RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 51 | 2.27e-01 | 0.097800 | 4.34e-01 |
| MEIOSIS | 66 | 1.71e-01 | -0.097500 | 3.62e-01 |
| ACYL CHAIN REMODELLING OF PC | 17 | 4.87e-01 | 0.097300 | 6.90e-01 |
| RHO GTPASE CYCLE | 426 | 6.19e-04 | 0.096900 | 5.61e-03 |
| THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 27 | 3.84e-01 | -0.096800 | 5.94e-01 |
| INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 4.12e-01 | -0.096700 | 6.23e-01 |
| P75 NTR RECEPTOR MEDIATED SIGNALLING | 94 | 1.06e-01 | 0.096500 | 2.65e-01 |
| ELASTIC FIBRE FORMATION | 38 | 3.05e-01 | 0.096300 | 5.21e-01 |
| TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 5.48e-01 | -0.096100 | 7.40e-01 |
| ESR MEDIATED SIGNALING | 168 | 3.18e-02 | -0.096100 | 1.22e-01 |
| REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 8.70e-02 | 0.095400 | 2.39e-01 |
| BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 5.85e-01 | 0.095200 | 7.69e-01 |
| PLASMA LIPOPROTEIN CLEARANCE | 28 | 3.84e-01 | 0.095200 | 5.94e-01 |
| REGULATION OF INSULIN SECRETION | 71 | 1.69e-01 | 0.094400 | 3.61e-01 |
| MRNA SPLICING | 188 | 2.63e-02 | -0.094100 | 1.07e-01 |
| RHO GTPASES ACTIVATE CIT | 18 | 4.91e-01 | 0.093700 | 6.94e-01 |
| GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 109 | 9.14e-02 | 0.093600 | 2.45e-01 |
| SIGNALING BY WNT | 270 | 8.50e-03 | -0.093200 | 4.66e-02 |
| DEUBIQUITINATION | 243 | 1.29e-02 | -0.092800 | 6.52e-02 |
| ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 29 | 3.88e-01 | -0.092700 | 5.98e-01 |
| DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 4.86e-01 | -0.092300 | 6.90e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 3.99e-01 | -0.092100 | 6.10e-01 |
| SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 2.22e-01 | 0.091900 | 4.27e-01 |
| REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 1.67e-01 | -0.091800 | 3.59e-01 |
| SIGNAL TRANSDUCTION BY L1 | 21 | 4.71e-01 | -0.090900 | 6.80e-01 |
| TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 95 | 1.28e-01 | -0.090300 | 3.00e-01 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 5.90e-01 | 0.089900 | 7.72e-01 |
| APOPTOTIC EXECUTION PHASE | 45 | 2.98e-01 | -0.089800 | 5.17e-01 |
| NONHOMOLOGOUS END JOINING NHEJ | 44 | 3.04e-01 | -0.089500 | 5.21e-01 |
| TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 92 | 1.40e-01 | -0.089100 | 3.19e-01 |
| KERATAN SULFATE BIOSYNTHESIS | 24 | 4.52e-01 | -0.088700 | 6.65e-01 |
| ACTIVATION OF BH3 ONLY PROTEINS | 30 | 4.01e-01 | -0.088500 | 6.10e-01 |
| GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 3.79e-01 | -0.088400 | 5.92e-01 |
| LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 5.82e-01 | -0.088200 | 7.68e-01 |
| SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 5.42e-01 | -0.088100 | 7.35e-01 |
| SARS COV INFECTIONS | 141 | 7.15e-02 | -0.088000 | 2.09e-01 |
| RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 1.57e-01 | -0.087800 | 3.44e-01 |
| SIGNALING BY FGFR1 | 44 | 3.14e-01 | -0.087700 | 5.31e-01 |
| MEIOTIC SYNAPSIS | 42 | 3.26e-01 | -0.087600 | 5.39e-01 |
| SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 6.00e-01 | -0.087500 | 7.80e-01 |
| TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 1.96e-01 | 0.086900 | 3.99e-01 |
| SIGNALING BY ERBB2 ECD MUTANTS | 16 | 5.48e-01 | -0.086700 | 7.40e-01 |
| PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 2.22e-02 | -0.086400 | 9.50e-02 |
| SIGNALING BY MET | 74 | 2.04e-01 | 0.085400 | 4.07e-01 |
| SELECTIVE AUTOPHAGY | 73 | 2.08e-01 | -0.085300 | 4.09e-01 |
| DAP12 SIGNALING | 24 | 4.71e-01 | -0.085100 | 6.80e-01 |
| FGFR2 ALTERNATIVE SPLICING | 25 | 4.62e-01 | -0.085000 | 6.73e-01 |
| RHO GTPASES ACTIVATE ROCKS | 19 | 5.23e-01 | 0.084700 | 7.16e-01 |
| TRANSCRIPTIONAL REGULATION BY TP53 | 346 | 6.94e-03 | -0.084600 | 4.03e-02 |
| HYALURONAN UPTAKE AND DEGRADATION | 12 | 6.13e-01 | 0.084300 | 7.85e-01 |
| IRS MEDIATED SIGNALLING | 40 | 3.58e-01 | -0.084000 | 5.70e-01 |
| DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 148 | 7.81e-02 | -0.084000 | 2.21e-01 |
| METABOLISM OF FOLATE AND PTERINES | 15 | 5.74e-01 | 0.083900 | 7.62e-01 |
| NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 3.16e-01 | 0.083700 | 5.31e-01 |
| ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 3.74e-01 | -0.083400 | 5.86e-01 |
| TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 6.18e-01 | -0.083100 | 7.87e-01 |
| SIGNALING BY FGFR IN DISEASE | 57 | 2.78e-01 | -0.083100 | 4.94e-01 |
| CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 24 | 4.82e-01 | -0.082900 | 6.87e-01 |
| RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 4.92e-01 | 0.082800 | 6.94e-01 |
| RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 3.27e-01 | -0.082700 | 5.39e-01 |
| THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 5.03e-01 | -0.082400 | 7.01e-01 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 6.07e-01 | -0.082400 | 7.82e-01 |
| RNA POLYMERASE II TRANSCRIPTION | 1100 | 4.94e-06 | -0.082100 | 9.06e-05 |
| PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 3.20e-01 | 0.082100 | 5.33e-01 |
| SIGNALING BY NTRKS | 130 | 1.07e-01 | -0.082000 | 2.65e-01 |
| PECAM1 INTERACTIONS | 12 | 6.24e-01 | 0.081700 | 7.92e-01 |
| DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 4.47e-01 | 0.081600 | 6.59e-01 |
| FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 2.89e-01 | -0.081200 | 5.07e-01 |
| HDACS DEACETYLATE HISTONES | 47 | 3.36e-01 | 0.081100 | 5.51e-01 |
| COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 1.82e-01 | -0.081000 | 3.77e-01 |
| RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 106 | 1.50e-01 | -0.081000 | 3.34e-01 |
| DEATH RECEPTOR SIGNALLING | 133 | 1.07e-01 | 0.080900 | 2.67e-01 |
| IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 22 | 5.13e-01 | -0.080500 | 7.09e-01 |
| SIGNALING BY ERBB2 | 48 | 3.37e-01 | -0.080100 | 5.52e-01 |
| IRAK1 RECRUITS IKK COMPLEX | 14 | 6.05e-01 | 0.079800 | 7.82e-01 |
| ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 6.47e-01 | 0.079700 | 8.11e-01 |
| TRANSMISSION ACROSS CHEMICAL SYNAPSES | 245 | 3.22e-02 | 0.079600 | 1.22e-01 |
| NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 6.49e-01 | 0.079200 | 8.11e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 88 | 2.01e-01 | -0.078900 | 4.05e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 6.66e-01 | -0.078800 | 8.19e-01 |
| DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 3.84e-01 | 0.078600 | 5.94e-01 |
| DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 45 | 3.63e-01 | -0.078400 | 5.74e-01 |
| SIGNALING BY NOTCH3 | 48 | 3.48e-01 | 0.078300 | 5.63e-01 |
| NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 96 | 1.86e-01 | -0.078100 | 3.84e-01 |
| SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 2.53e-01 | -0.078000 | 4.65e-01 |
| HCMV INFECTION | 104 | 1.70e-01 | -0.077900 | 3.61e-01 |
| METAL ION SLC TRANSPORTERS | 25 | 5.01e-01 | 0.077800 | 7.00e-01 |
| POLO LIKE KINASE MEDIATED EVENTS | 14 | 6.16e-01 | -0.077400 | 7.86e-01 |
| SIGNALING BY EGFR | 47 | 3.59e-01 | 0.077300 | 5.70e-01 |
| MYOGENESIS | 25 | 5.04e-01 | 0.077200 | 7.01e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 24 | 5.15e-01 | -0.076800 | 7.09e-01 |
| MHC CLASS II ANTIGEN PRESENTATION | 101 | 1.83e-01 | -0.076800 | 3.79e-01 |
| CELL CELL JUNCTION ORGANIZATION | 49 | 3.53e-01 | -0.076800 | 5.68e-01 |
| KERATAN SULFATE DEGRADATION | 11 | 6.60e-01 | 0.076600 | 8.18e-01 |
| G ALPHA S SIGNALLING EVENTS | 108 | 1.69e-01 | 0.076600 | 3.61e-01 |
| SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 6.47e-01 | -0.076400 | 8.11e-01 |
| N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 4.37e-01 | -0.075900 | 6.48e-01 |
| CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 93 | 2.08e-01 | -0.075700 | 4.09e-01 |
| SIGNALING BY NODAL | 15 | 6.12e-01 | -0.075500 | 7.85e-01 |
| SHC MEDIATED CASCADE FGFR4 | 12 | 6.51e-01 | -0.075300 | 8.12e-01 |
| NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 5.64e-01 | 0.074600 | 7.53e-01 |
| COMPLEMENT CASCADE | 27 | 5.04e-01 | 0.074300 | 7.01e-01 |
| SIGNALING BY TGFB FAMILY MEMBERS | 97 | 2.09e-01 | -0.073900 | 4.10e-01 |
| KILLING MECHANISMS | 11 | 6.72e-01 | 0.073700 | 8.25e-01 |
| ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 5.44e-01 | -0.073100 | 7.37e-01 |
| FGFR1 MUTANT RECEPTOR ACTIVATION | 26 | 5.20e-01 | 0.072900 | 7.14e-01 |
| SIGNALLING TO ERKS | 34 | 4.63e-01 | -0.072800 | 6.74e-01 |
| ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 27 | 5.13e-01 | -0.072700 | 7.09e-01 |
| RHOBTB GTPASE CYCLE | 35 | 4.59e-01 | -0.072300 | 6.70e-01 |
| PYRIMIDINE SALVAGE | 10 | 6.93e-01 | 0.072200 | 8.36e-01 |
| ACTIVATION OF PPARGC1A PGC 1ALPHA BY PHOSPHORYLATION | 10 | 6.93e-01 | 0.072100 | 8.36e-01 |
| RHOJ GTPASE CYCLE | 55 | 3.56e-01 | 0.071900 | 5.69e-01 |
| HSF1 DEPENDENT TRANSACTIVATION | 34 | 4.72e-01 | 0.071200 | 6.82e-01 |
| RAB REGULATION OF TRAFFICKING | 118 | 1.84e-01 | -0.070800 | 3.80e-01 |
| MUSCLE CONTRACTION | 164 | 1.18e-01 | 0.070800 | 2.86e-01 |
| SLC MEDIATED TRANSMEMBRANE TRANSPORT | 195 | 8.91e-02 | 0.070700 | 2.42e-01 |
| PROLACTIN RECEPTOR SIGNALING | 11 | 6.85e-01 | -0.070600 | 8.32e-01 |
| DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 6.60e-01 | -0.070500 | 8.18e-01 |
| CELLULAR RESPONSE TO HEAT STRESS | 95 | 2.35e-01 | -0.070500 | 4.44e-01 |
| OTHER INTERLEUKIN SIGNALING | 20 | 5.86e-01 | 0.070400 | 7.69e-01 |
| SIGNALING BY EGFR IN CANCER | 22 | 5.68e-01 | -0.070300 | 7.58e-01 |
| VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 5.34e-01 | -0.069200 | 7.29e-01 |
| VLDLR INTERNALISATION AND DEGRADATION | 12 | 6.79e-01 | 0.069000 | 8.28e-01 |
| SIGNALING BY NUCLEAR RECEPTORS | 227 | 7.38e-02 | -0.069000 | 2.14e-01 |
| ENDOGENOUS STEROLS | 20 | 5.95e-01 | 0.068600 | 7.76e-01 |
| LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 5.96e-01 | -0.068500 | 7.76e-01 |
| GAP JUNCTION DEGRADATION | 11 | 6.95e-01 | -0.068200 | 8.38e-01 |
| RAP1 SIGNALLING | 15 | 6.48e-01 | -0.068000 | 8.11e-01 |
| COLLAGEN DEGRADATION | 51 | 4.01e-01 | 0.068000 | 6.10e-01 |
| TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 6.84e-01 | -0.067900 | 8.31e-01 |
| INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 2.98e-01 | -0.067800 | 5.18e-01 |
| PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 5.35e-01 | -0.067700 | 7.29e-01 |
| CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 4.82e-01 | 0.067700 | 6.87e-01 |
| REDUCTION OF CYTOSOLIC CA LEVELS | 12 | 6.86e-01 | 0.067500 | 8.32e-01 |
| RHO GTPASE EFFECTORS | 252 | 6.81e-02 | -0.066800 | 2.00e-01 |
| SIGNALING BY FGFR | 75 | 3.19e-01 | -0.066600 | 5.32e-01 |
| SIGNALING BY NOTCH2 | 33 | 5.08e-01 | 0.066600 | 7.04e-01 |
| SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 4.55e-01 | 0.066600 | 6.67e-01 |
| INSULIN RECEPTOR SIGNALLING CASCADE | 45 | 4.40e-01 | -0.066600 | 6.51e-01 |
| VXPX CARGO TARGETING TO CILIUM | 19 | 6.16e-01 | 0.066400 | 7.86e-01 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 5.82e-01 | -0.066300 | 7.68e-01 |
| CILIUM ASSEMBLY | 193 | 1.14e-01 | 0.066100 | 2.79e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 6.10e-01 | 0.066000 | 7.85e-01 |
| TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 6.51e-01 | -0.065400 | 8.12e-01 |
| TRP CHANNELS | 20 | 6.13e-01 | 0.065300 | 7.85e-01 |
| FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 6.73e-01 | 0.065100 | 8.25e-01 |
| SUMOYLATION OF RNA BINDING PROTEINS | 45 | 4.53e-01 | -0.064700 | 6.65e-01 |
| SIGNALING BY FGFR2 | 64 | 3.71e-01 | -0.064600 | 5.83e-01 |
| RHOBTB1 GTPASE CYCLE | 23 | 5.92e-01 | -0.064600 | 7.73e-01 |
| NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 5.70e-01 | 0.064400 | 7.59e-01 |
| MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 5.54e-01 | -0.063400 | 7.44e-01 |
| ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 6.82e-01 | 0.063200 | 8.31e-01 |
| POTASSIUM CHANNELS | 91 | 2.98e-01 | 0.063100 | 5.18e-01 |
| TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 7.19e-01 | -0.062700 | 8.54e-01 |
| CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 5.81e-01 | 0.062600 | 7.68e-01 |
| ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 6.22e-01 | -0.062200 | 7.91e-01 |
| SIGNALING BY KIT IN DISEASE | 20 | 6.31e-01 | -0.062100 | 7.96e-01 |
| OVARIAN TUMOR DOMAIN PROTEASES | 37 | 5.15e-01 | -0.061900 | 7.09e-01 |
| GLYCOSAMINOGLYCAN METABOLISM | 115 | 2.52e-01 | 0.061800 | 4.65e-01 |
| TRIGLYCERIDE BIOSYNTHESIS | 10 | 7.39e-01 | -0.060900 | 8.66e-01 |
| PHOSPHOLIPID METABOLISM | 187 | 1.52e-01 | 0.060800 | 3.36e-01 |
| VIRAL MESSENGER RNA SYNTHESIS | 42 | 4.96e-01 | -0.060700 | 6.97e-01 |
| SIGNALING BY PDGF | 57 | 4.28e-01 | 0.060700 | 6.38e-01 |
| REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 7.06e-01 | 0.060500 | 8.45e-01 |
| RHOQ GTPASE CYCLE | 59 | 4.22e-01 | 0.060500 | 6.32e-01 |
| CLATHRIN MEDIATED ENDOCYTOSIS | 133 | 2.29e-01 | -0.060400 | 4.36e-01 |
| REGULATION OF KIT SIGNALING | 16 | 6.76e-01 | 0.060400 | 8.26e-01 |
| TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 62 | 4.13e-01 | -0.060200 | 6.23e-01 |
| SIGNALING BY BMP | 25 | 6.03e-01 | -0.060100 | 7.80e-01 |
| GAB1 SIGNALOSOME | 14 | 6.97e-01 | 0.060000 | 8.39e-01 |
| REGULATED PROTEOLYSIS OF P75NTR | 12 | 7.19e-01 | 0.059900 | 8.54e-01 |
| PLATELET ACTIVATION SIGNALING AND AGGREGATION | 222 | 1.25e-01 | -0.059900 | 2.96e-01 |
| SIGNALING BY GPCR | 486 | 2.43e-02 | 0.059800 | 1.02e-01 |
| ONCOGENIC MAPK SIGNALING | 76 | 3.68e-01 | 0.059800 | 5.79e-01 |
| VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 6.91e-01 | -0.059300 | 8.35e-01 |
| ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 7.34e-01 | -0.059200 | 8.63e-01 |
| KERATAN SULFATE KERATIN METABOLISM | 30 | 5.75e-01 | -0.059200 | 7.62e-01 |
| POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 63 | 4.17e-01 | -0.059100 | 6.27e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 26 | 6.02e-01 | -0.059100 | 7.80e-01 |
| ATTENUATION PHASE | 24 | 6.17e-01 | 0.059100 | 7.86e-01 |
| RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 4.81e-01 | -0.058800 | 6.87e-01 |
| INTRAFLAGELLAR TRANSPORT | 52 | 4.65e-01 | 0.058600 | 6.76e-01 |
| INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 5.50e-01 | -0.058300 | 7.40e-01 |
| TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 70 | 4.00e-01 | 0.058200 | 6.10e-01 |
| MITOTIC PROMETAPHASE | 177 | 1.84e-01 | -0.057900 | 3.80e-01 |
| CARDIAC CONDUCTION | 109 | 3.01e-01 | 0.057400 | 5.19e-01 |
| DNA DOUBLE STRAND BREAK REPAIR | 136 | 2.52e-01 | -0.056900 | 4.65e-01 |
| SIGNALING BY NTRK2 TRKB | 24 | 6.30e-01 | 0.056700 | 7.96e-01 |
| SPRY REGULATION OF FGF SIGNALING | 16 | 6.97e-01 | -0.056100 | 8.39e-01 |
| MICRORNA MIRNA BIOGENESIS | 24 | 6.36e-01 | 0.055900 | 7.99e-01 |
| TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 32 | 5.85e-01 | -0.055800 | 7.69e-01 |
| METABOLISM OF LIPIDS | 616 | 1.86e-02 | -0.055800 | 8.47e-02 |
| METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 6.67e-01 | -0.055700 | 8.19e-01 |
| POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 6.24e-01 | -0.055600 | 7.92e-01 |
| VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 6.75e-01 | -0.055600 | 8.26e-01 |
| AMINE LIGAND BINDING RECEPTORS | 28 | 6.11e-01 | 0.055600 | 7.85e-01 |
| TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 11 | 7.50e-01 | 0.055500 | 8.74e-01 |
| SYNDECAN INTERACTIONS | 26 | 6.25e-01 | 0.055500 | 7.92e-01 |
| RNA POLYMERASE III TRANSCRIPTION | 41 | 5.41e-01 | -0.055200 | 7.35e-01 |
| PYRIMIDINE CATABOLISM | 10 | 7.64e-01 | -0.054900 | 8.83e-01 |
| DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 6.50e-01 | -0.054700 | 8.11e-01 |
| BASIGIN INTERACTIONS | 22 | 6.58e-01 | -0.054600 | 8.17e-01 |
| CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 6.91e-01 | -0.054100 | 8.35e-01 |
| VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 38 | 5.64e-01 | -0.054100 | 7.53e-01 |
| JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 6.63e-01 | -0.053700 | 8.19e-01 |
| SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 7.12e-01 | 0.053400 | 8.50e-01 |
| ESTROGEN DEPENDENT GENE EXPRESSION | 104 | 3.52e-01 | -0.052900 | 5.68e-01 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 7.42e-01 | 0.052800 | 8.67e-01 |
| MEMBRANE TRAFFICKING | 581 | 3.20e-02 | -0.052200 | 1.22e-01 |
| TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 16 | 7.20e-01 | 0.051700 | 8.54e-01 |
| INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 6.02e-01 | -0.051700 | 7.80e-01 |
| CHEMOKINE RECEPTORS BIND CHEMOKINES | 18 | 7.06e-01 | -0.051400 | 8.45e-01 |
| HATS ACETYLATE HISTONES | 94 | 3.90e-01 | 0.051300 | 6.00e-01 |
| MITOCHONDRIAL BIOGENESIS | 93 | 4.02e-01 | -0.050300 | 6.10e-01 |
| TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 6.06e-01 | 0.050300 | 7.82e-01 |
| METABOLISM OF STEROIDS | 115 | 3.55e-01 | 0.049900 | 5.69e-01 |
| TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 5.02e-01 | -0.049700 | 7.01e-01 |
| ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 6.64e-01 | -0.049300 | 8.19e-01 |
| CALNEXIN CALRETICULIN CYCLE | 26 | 6.64e-01 | -0.049200 | 8.19e-01 |
| VESICLE MEDIATED TRANSPORT | 614 | 4.16e-02 | -0.048300 | 1.45e-01 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 7.92e-01 | -0.048100 | 9.01e-01 |
| EPIGENETIC REGULATION OF GENE EXPRESSION | 104 | 3.99e-01 | -0.047900 | 6.10e-01 |
| FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 25 | 6.84e-01 | 0.047000 | 8.31e-01 |
| IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 14 | 7.61e-01 | 0.046900 | 8.83e-01 |
| ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 53 | 5.56e-01 | 0.046800 | 7.45e-01 |
| ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 76 | 4.85e-01 | -0.046300 | 6.89e-01 |
| NEGATIVE REGULATION OF MET ACTIVITY | 20 | 7.20e-01 | -0.046300 | 8.54e-01 |
| RESOLUTION OF D LOOP STRUCTURES | 30 | 6.63e-01 | -0.045900 | 8.19e-01 |
| SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 630 | 5.06e-02 | 0.045800 | 1.65e-01 |
| NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 183 | 2.87e-01 | 0.045700 | 5.04e-01 |
| PLASMA LIPOPROTEIN REMODELING | 14 | 7.67e-01 | 0.045700 | 8.83e-01 |
| TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 6.16e-01 | 0.045300 | 7.86e-01 |
| NUCLEAR ENVELOPE BREAKDOWN | 50 | 5.79e-01 | -0.045300 | 7.67e-01 |
| G PROTEIN ACTIVATION | 22 | 7.15e-01 | -0.045000 | 8.52e-01 |
| RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 79 | 4.91e-01 | 0.044800 | 6.94e-01 |
| SIGNALING BY CSF3 G CSF | 29 | 6.77e-01 | -0.044600 | 8.27e-01 |
| ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 85 | 4.78e-01 | 0.044500 | 6.87e-01 |
| RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 5.09e-01 | -0.044400 | 7.04e-01 |
| NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 7.99e-01 | -0.044300 | 9.03e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 16 | 7.59e-01 | 0.044200 | 8.82e-01 |
| CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 8.09e-01 | 0.044200 | 9.07e-01 |
| ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 8.02e-01 | -0.043600 | 9.04e-01 |
| ERYTHROPOIETIN ACTIVATES RAS | 13 | 7.85e-01 | -0.043600 | 8.96e-01 |
| NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 5.87e-01 | -0.043600 | 7.70e-01 |
| REPRODUCTION | 79 | 5.05e-01 | -0.043500 | 7.01e-01 |
| CA2 PATHWAY | 58 | 5.74e-01 | 0.042700 | 7.62e-01 |
| O LINKED GLYCOSYLATION OF MUCINS | 42 | 6.33e-01 | -0.042700 | 7.98e-01 |
| RAC3 GTPASE CYCLE | 91 | 4.83e-01 | 0.042600 | 6.87e-01 |
| CELLULAR HEXOSE TRANSPORT | 11 | 8.07e-01 | 0.042500 | 9.07e-01 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 7.99e-01 | 0.042400 | 9.03e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 19 | 7.49e-01 | 0.042400 | 8.74e-01 |
| MAPK FAMILY SIGNALING CASCADES | 290 | 2.15e-01 | -0.042400 | 4.18e-01 |
| ACYL CHAIN REMODELLING OF PE | 17 | 7.67e-01 | -0.041600 | 8.83e-01 |
| MAP2K AND MAPK ACTIVATION | 36 | 6.69e-01 | 0.041200 | 8.21e-01 |
| RND1 GTPASE CYCLE | 38 | 6.62e-01 | 0.041000 | 8.19e-01 |
| INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 286 | 2.39e-01 | -0.040500 | 4.49e-01 |
| PREGNENOLONE BIOSYNTHESIS | 12 | 8.09e-01 | -0.040400 | 9.07e-01 |
| PLASMA LIPOPROTEIN ASSEMBLY | 12 | 8.09e-01 | 0.040300 | 9.07e-01 |
| SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 7.81e-01 | 0.040200 | 8.95e-01 |
| DNA DOUBLE STRAND BREAK RESPONSE | 53 | 6.13e-01 | 0.040200 | 7.85e-01 |
| TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 6.53e-01 | -0.039700 | 8.13e-01 |
| ORGANIC CATION ANION ZWITTERION TRANSPORT | 11 | 8.21e-01 | 0.039400 | 9.11e-01 |
| GLYCOGEN METABOLISM | 25 | 7.34e-01 | 0.039300 | 8.63e-01 |
| RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 5.86e-01 | -0.039100 | 7.69e-01 |
| SIGNALLING TO RAS | 20 | 7.62e-01 | 0.039100 | 8.83e-01 |
| ADHERENS JUNCTIONS INTERACTIONS | 30 | 7.12e-01 | 0.038900 | 8.50e-01 |
| EGFR DOWNREGULATION | 28 | 7.22e-01 | -0.038900 | 8.54e-01 |
| RAC2 GTPASE CYCLE | 88 | 5.29e-01 | 0.038900 | 7.22e-01 |
| IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 8.33e-01 | -0.038500 | 9.17e-01 |
| TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 45 | 6.55e-01 | 0.038500 | 8.15e-01 |
| JOSEPHIN DOMAIN DUBS | 11 | 8.25e-01 | -0.038500 | 9.12e-01 |
| SIGNALING BY FGFR1 IN DISEASE | 33 | 7.04e-01 | 0.038300 | 8.44e-01 |
| RHOD GTPASE CYCLE | 51 | 6.39e-01 | 0.038000 | 8.02e-01 |
| REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 7.26e-01 | 0.037600 | 8.58e-01 |
| COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 5.49e-01 | 0.037400 | 7.40e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX1 | 181 | 3.87e-01 | -0.037300 | 5.98e-01 |
| ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 33 | 7.11e-01 | -0.037300 | 8.50e-01 |
| RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 86 | 5.51e-01 | 0.037200 | 7.40e-01 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 8.10e-01 | 0.037200 | 9.07e-01 |
| UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 7.35e-01 | 0.037000 | 8.64e-01 |
| SIGNALING BY VEGF | 104 | 5.15e-01 | -0.037000 | 7.09e-01 |
| AURKA ACTIVATION BY TPX2 | 72 | 5.88e-01 | 0.037000 | 7.70e-01 |
| SODIUM CALCIUM EXCHANGERS | 10 | 8.41e-01 | -0.036700 | 9.20e-01 |
| FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 47 | 6.65e-01 | 0.036500 | 8.19e-01 |
| NEGATIVE REGULATION OF FGFR4 SIGNALING | 23 | 7.62e-01 | -0.036400 | 8.83e-01 |
| INTERLEUKIN 27 SIGNALING | 10 | 8.42e-01 | 0.036400 | 9.20e-01 |
| SCAVENGING BY CLASS A RECEPTORS | 15 | 8.09e-01 | -0.036100 | 9.07e-01 |
| TELOMERE EXTENSION BY TELOMERASE | 22 | 7.70e-01 | 0.036100 | 8.85e-01 |
| REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 8.37e-01 | -0.035900 | 9.18e-01 |
| SIGNALING BY BRAF AND RAF FUSIONS | 60 | 6.34e-01 | 0.035500 | 7.98e-01 |
| PROCESSING OF INTRONLESS PRE MRNAS | 19 | 7.92e-01 | -0.035000 | 9.01e-01 |
| FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 81 | 5.90e-01 | -0.034600 | 7.72e-01 |
| CLASS A 1 RHODOPSIN LIKE RECEPTORS | 188 | 4.16e-01 | 0.034400 | 6.27e-01 |
| SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 46 | 6.87e-01 | -0.034400 | 8.32e-01 |
| UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 8.45e-01 | 0.034100 | 9.21e-01 |
| SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 8.45e-01 | -0.034000 | 9.21e-01 |
| GROWTH HORMONE RECEPTOR SIGNALING | 20 | 7.94e-01 | -0.033800 | 9.02e-01 |
| MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 8.16e-01 | 0.033700 | 9.08e-01 |
| GLUCOSE METABOLISM | 81 | 6.03e-01 | -0.033500 | 7.80e-01 |
| SIGNALING BY HEDGEHOG | 142 | 5.00e-01 | 0.032800 | 7.00e-01 |
| GABA RECEPTOR ACTIVATION | 55 | 6.76e-01 | -0.032600 | 8.26e-01 |
| SIGNALING BY SCF KIT | 41 | 7.20e-01 | 0.032300 | 8.54e-01 |
| NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 7.90e-01 | 0.032100 | 9.00e-01 |
| METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 5.73e-01 | -0.032100 | 7.62e-01 |
| DISEASES OF CARBOHYDRATE METABOLISM | 29 | 7.65e-01 | 0.032100 | 8.83e-01 |
| SIGNALING BY ERBB2 IN CANCER | 25 | 7.81e-01 | -0.032100 | 8.95e-01 |
| REPRESSION OF WNT TARGET GENES | 14 | 8.36e-01 | 0.032000 | 9.18e-01 |
| FANCONI ANEMIA PATHWAY | 36 | 7.42e-01 | -0.031700 | 8.67e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 8.13e-01 | -0.031300 | 9.08e-01 |
| SIGNALING BY HIPPO | 20 | 8.11e-01 | 0.030900 | 9.07e-01 |
| EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 7.82e-01 | 0.030800 | 8.95e-01 |
| SUMOYLATION OF DNA REPLICATION PROTEINS | 42 | 7.31e-01 | -0.030700 | 8.62e-01 |
| DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 368 | 3.17e-01 | -0.030400 | 5.31e-01 |
| THE PHOTOTRANSDUCTION CASCADE | 21 | 8.11e-01 | 0.030200 | 9.07e-01 |
| SHC MEDIATED CASCADE FGFR3 | 13 | 8.51e-01 | -0.030100 | 9.23e-01 |
| SUMOYLATION | 164 | 5.21e-01 | -0.029100 | 7.14e-01 |
| EPH EPHRIN SIGNALING | 92 | 6.31e-01 | -0.029000 | 7.96e-01 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 8.46e-01 | -0.028900 | 9.21e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 46 | 7.36e-01 | -0.028800 | 8.64e-01 |
| PI 3K CASCADE FGFR3 | 13 | 8.59e-01 | 0.028500 | 9.26e-01 |
| SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 8.22e-01 | -0.028400 | 9.11e-01 |
| ORGANELLE BIOGENESIS AND MAINTENANCE | 286 | 4.11e-01 | 0.028300 | 6.23e-01 |
| SIGNALING BY ERYTHROPOIETIN | 24 | 8.14e-01 | 0.027700 | 9.08e-01 |
| GLUCAGON SIGNALING IN METABOLIC REGULATION | 30 | 7.97e-01 | 0.027100 | 9.03e-01 |
| INSULIN PROCESSING | 24 | 8.18e-01 | -0.027100 | 9.10e-01 |
| SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 8.77e-01 | 0.027000 | 9.41e-01 |
| GPCR LIGAND BINDING | 271 | 4.47e-01 | 0.026900 | 6.59e-01 |
| AGGREPHAGY | 35 | 7.91e-01 | 0.025900 | 9.01e-01 |
| SURFACTANT METABOLISM | 16 | 8.59e-01 | -0.025700 | 9.26e-01 |
| CELL JUNCTION ORGANIZATION | 74 | 7.04e-01 | -0.025600 | 8.44e-01 |
| TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 7.72e-01 | -0.025500 | 8.87e-01 |
| REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 7.39e-01 | -0.025100 | 8.66e-01 |
| CIRCADIAN CLOCK | 68 | 7.21e-01 | 0.025100 | 8.54e-01 |
| RHOF GTPASE CYCLE | 41 | 7.83e-01 | -0.024800 | 8.96e-01 |
| ZINC TRANSPORTERS | 16 | 8.64e-01 | 0.024800 | 9.30e-01 |
| LEISHMANIA INFECTION | 199 | 5.51e-01 | -0.024600 | 7.40e-01 |
| METABOLISM OF VITAMINS AND COFACTORS | 154 | 6.00e-01 | -0.024500 | 7.80e-01 |
| DOWNREGULATION OF ERBB2 SIGNALING | 28 | 8.24e-01 | -0.024300 | 9.12e-01 |
| ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 8.41e-01 | 0.024200 | 9.20e-01 |
| CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 8.98e-01 | -0.023500 | 9.51e-01 |
| NUCLEAR IMPORT OF REV PROTEIN | 32 | 8.19e-01 | -0.023400 | 9.10e-01 |
| SIGNALING BY ACTIVIN | 12 | 8.89e-01 | -0.023300 | 9.45e-01 |
| SIGNALING BY RECEPTOR TYROSINE KINASES | 467 | 3.91e-01 | -0.023200 | 6.00e-01 |
| HDR THROUGH MMEJ ALT NHEJ | 10 | 9.01e-01 | -0.022700 | 9.51e-01 |
| G ALPHA Q SIGNALLING EVENTS | 157 | 6.25e-01 | 0.022600 | 7.92e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 8.84e-01 | 0.022400 | 9.44e-01 |
| SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 8.14e-01 | -0.022300 | 9.08e-01 |
| RHOG GTPASE CYCLE | 74 | 7.40e-01 | 0.022300 | 8.67e-01 |
| MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 8.82e-01 | -0.022200 | 9.43e-01 |
| REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 91 | 7.16e-01 | -0.022100 | 8.53e-01 |
| VISUAL PHOTOTRANSDUCTION | 61 | 7.67e-01 | 0.021900 | 8.83e-01 |
| STRIATED MUSCLE CONTRACTION | 28 | 8.41e-01 | 0.021900 | 9.20e-01 |
| NUCLEOBASE CATABOLISM | 31 | 8.34e-01 | -0.021800 | 9.17e-01 |
| CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 63 | 7.66e-01 | -0.021700 | 8.83e-01 |
| CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 8.65e-01 | 0.021500 | 9.30e-01 |
| PEPTIDE LIGAND BINDING RECEPTORS | 112 | 6.98e-01 | 0.021200 | 8.39e-01 |
| G ALPHA I SIGNALLING EVENTS | 205 | 6.05e-01 | 0.021000 | 7.82e-01 |
| CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 93 | 7.27e-01 | -0.020900 | 8.58e-01 |
| PLATELET HOMEOSTASIS | 78 | 7.53e-01 | -0.020600 | 8.76e-01 |
| GABA B RECEPTOR ACTIVATION | 40 | 8.22e-01 | 0.020500 | 9.11e-01 |
| REGULATION OF TP53 EXPRESSION AND DEGRADATION | 36 | 8.32e-01 | -0.020500 | 9.16e-01 |
| SIGNALING BY NOTCH | 190 | 6.34e-01 | -0.020100 | 7.98e-01 |
| RECYCLING PATHWAY OF L1 | 40 | 8.28e-01 | -0.019900 | 9.14e-01 |
| SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 8.45e-01 | -0.019600 | 9.21e-01 |
| FRS MEDIATED FGFR4 SIGNALING | 14 | 9.01e-01 | -0.019200 | 9.51e-01 |
| TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 8.57e-01 | 0.019000 | 9.26e-01 |
| APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 8.50e-01 | 0.018800 | 9.23e-01 |
| NUCLEOTIDE SALVAGE | 21 | 8.82e-01 | -0.018700 | 9.43e-01 |
| SLC TRANSPORTER DISORDERS | 77 | 7.82e-01 | 0.018300 | 8.95e-01 |
| DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 8.87e-01 | -0.017900 | 9.44e-01 |
| CLASS B 2 SECRETIN FAMILY RECEPTORS | 71 | 7.98e-01 | -0.017500 | 9.03e-01 |
| TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 9.14e-01 | -0.017300 | 9.56e-01 |
| CELL CELL COMMUNICATION | 107 | 7.58e-01 | 0.017300 | 8.81e-01 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 9.15e-01 | 0.017100 | 9.56e-01 |
| FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 9.09e-01 | 0.017100 | 9.53e-01 |
| ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 120 | 7.47e-01 | 0.017000 | 8.72e-01 |
| SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 9.02e-01 | -0.016800 | 9.51e-01 |
| SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 8.56e-01 | 0.016400 | 9.26e-01 |
| ACYL CHAIN REMODELLING OF PG | 10 | 9.29e-01 | -0.016300 | 9.64e-01 |
| FRS MEDIATED FGFR3 SIGNALING | 15 | 9.13e-01 | 0.016300 | 9.56e-01 |
| REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 86 | 7.96e-01 | 0.016100 | 9.03e-01 |
| REGULATION OF BETA CELL DEVELOPMENT | 29 | 8.81e-01 | 0.016100 | 9.43e-01 |
| PHASE I FUNCTIONALIZATION OF COMPOUNDS | 59 | 8.32e-01 | -0.016000 | 9.16e-01 |
| CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 9.04e-01 | -0.015900 | 9.51e-01 |
| DSCAM INTERACTIONS | 11 | 9.29e-01 | 0.015500 | 9.64e-01 |
| NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 45 | 8.58e-01 | 0.015400 | 9.26e-01 |
| TRNA AMINOACYLATION | 42 | 8.64e-01 | -0.015300 | 9.30e-01 |
| PI METABOLISM | 79 | 8.15e-01 | 0.015200 | 9.08e-01 |
| RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 9.04e-01 | -0.015200 | 9.51e-01 |
| REGULATION OF SIGNALING BY CBL | 22 | 9.03e-01 | 0.015100 | 9.51e-01 |
| NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 8.75e-01 | -0.015000 | 9.39e-01 |
| EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 8.85e-01 | -0.015000 | 9.44e-01 |
| SIGNALING BY FGFR4 | 33 | 8.82e-01 | -0.014900 | 9.43e-01 |
| CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 9.33e-01 | -0.014700 | 9.66e-01 |
| TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 8.26e-01 | 0.014300 | 9.12e-01 |
| COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 9.26e-01 | -0.014300 | 9.63e-01 |
| SIGNALING BY FGFR3 | 35 | 8.84e-01 | 0.014200 | 9.44e-01 |
| HEDGEHOG OFF STATE | 107 | 8.02e-01 | -0.014000 | 9.04e-01 |
| GLYCOGEN STORAGE DISEASES | 12 | 9.35e-01 | -0.013700 | 9.67e-01 |
| NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 9.09e-01 | -0.013500 | 9.53e-01 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 9.26e-01 | -0.013400 | 9.63e-01 |
| CELLULAR SENESCENCE | 143 | 7.84e-01 | -0.013300 | 8.96e-01 |
| HS GAG BIOSYNTHESIS | 30 | 9.02e-01 | 0.013000 | 9.51e-01 |
| SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 9.42e-01 | -0.012800 | 9.71e-01 |
| SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 9.04e-01 | 0.012500 | 9.51e-01 |
| DECTIN 2 FAMILY | 10 | 9.47e-01 | -0.012200 | 9.73e-01 |
| HCMV EARLY EVENTS | 81 | 8.50e-01 | 0.012100 | 9.23e-01 |
| PI 3K CASCADE FGFR4 | 12 | 9.43e-01 | -0.011900 | 9.72e-01 |
| DEVELOPMENTAL BIOLOGY | 832 | 5.77e-01 | 0.011400 | 7.65e-01 |
| INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 7.95e-01 | -0.011100 | 9.02e-01 |
| GOLGI TO ER RETROGRADE TRANSPORT | 119 | 8.39e-01 | -0.010800 | 9.20e-01 |
| NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 33 | 9.16e-01 | 0.010600 | 9.56e-01 |
| HIV ELONGATION ARREST AND RECOVERY | 32 | 9.18e-01 | -0.010500 | 9.57e-01 |
| SIGNALING BY PTK6 | 50 | 9.00e-01 | -0.010300 | 9.51e-01 |
| OXIDATIVE STRESS INDUCED SENESCENCE | 79 | 8.86e-01 | 0.009300 | 9.44e-01 |
| SIGNALING BY ERBB4 | 57 | 9.05e-01 | -0.009170 | 9.51e-01 |
| PI3K EVENTS IN ERBB2 SIGNALING | 15 | 9.52e-01 | -0.008960 | 9.75e-01 |
| REGULATION OF TP53 ACTIVITY | 154 | 8.53e-01 | -0.008680 | 9.24e-01 |
| REGULATION OF FZD BY UBIQUITINATION | 19 | 9.48e-01 | 0.008580 | 9.73e-01 |
| SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 9.15e-01 | 0.008520 | 9.56e-01 |
| GLYCOLYSIS | 67 | 9.04e-01 | -0.008510 | 9.51e-01 |
| SIGNALING BY WNT IN CANCER | 31 | 9.36e-01 | 0.008380 | 9.67e-01 |
| SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 58 | 9.13e-01 | -0.008340 | 9.56e-01 |
| CARNITINE METABOLISM | 14 | 9.57e-01 | -0.008240 | 9.76e-01 |
| TRAF6 MEDIATED NF KB ACTIVATION | 22 | 9.48e-01 | 0.008000 | 9.73e-01 |
| GENE SILENCING BY RNA | 83 | 9.02e-01 | 0.007790 | 9.51e-01 |
| FCERI MEDIATED CA 2 MOBILIZATION | 26 | 9.46e-01 | -0.007680 | 9.73e-01 |
| CGMP EFFECTS | 15 | 9.60e-01 | 0.007490 | 9.77e-01 |
| EPHRIN SIGNALING | 19 | 9.55e-01 | 0.007460 | 9.75e-01 |
| CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 9.49e-01 | -0.006930 | 9.73e-01 |
| EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 9.32e-01 | -0.006890 | 9.66e-01 |
| METABOLISM OF CARBOHYDRATES | 261 | 8.51e-01 | 0.006770 | 9.23e-01 |
| FORMATION OF THE CORNIFIED ENVELOPE | 27 | 9.54e-01 | 0.006470 | 9.75e-01 |
| KERATINIZATION | 27 | 9.54e-01 | 0.006470 | 9.75e-01 |
| MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 9.63e-01 | -0.005960 | 9.79e-01 |
| UNFOLDED PROTEIN RESPONSE UPR | 85 | 9.26e-01 | -0.005850 | 9.63e-01 |
| NUCLEAR SIGNALING BY ERBB4 | 31 | 9.59e-01 | 0.005370 | 9.77e-01 |
| GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 39 | 9.54e-01 | 0.005340 | 9.75e-01 |
| INTEGRIN CELL SURFACE INTERACTIONS | 74 | 9.38e-01 | -0.005190 | 9.69e-01 |
| PI3K AKT SIGNALING IN CANCER | 90 | 9.33e-01 | -0.005150 | 9.66e-01 |
| ERBB2 REGULATES CELL MOTILITY | 14 | 9.74e-01 | -0.004940 | 9.88e-01 |
| TRANSPORT OF SMALL MOLECULES | 590 | 8.70e-01 | -0.003960 | 9.35e-01 |
| CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 9.61e-01 | -0.003650 | 9.78e-01 |
| MITOTIC TELOPHASE CYTOKINESIS | 13 | 9.83e-01 | 0.003380 | 9.92e-01 |
| SIGNALING BY PDGFR IN DISEASE | 20 | 9.80e-01 | -0.003280 | 9.91e-01 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 9.83e-01 | 0.003200 | 9.92e-01 |
| INTRA GOLGI TRAFFIC | 43 | 9.72e-01 | -0.003120 | 9.87e-01 |
| BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 35 | 9.76e-01 | 0.002970 | 9.88e-01 |
| TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 9.80e-01 | -0.002550 | 9.91e-01 |
| LDL CLEARANCE | 16 | 9.88e-01 | -0.002220 | 9.93e-01 |
| ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 9.91e-01 | -0.002030 | 9.95e-01 |
| OPIOID SIGNALLING | 86 | 9.74e-01 | 0.002020 | 9.88e-01 |
| HEMOSTASIS | 475 | 9.45e-01 | 0.001850 | 9.73e-01 |
| TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 9.85e-01 | 0.001810 | 9.92e-01 |
| SYNTHESIS OF PC | 27 | 9.88e-01 | -0.001680 | 9.93e-01 |
| POTENTIAL THERAPEUTICS FOR SARS | 78 | 9.85e-01 | -0.001240 | 9.92e-01 |
| CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 9.95e-01 | -0.001030 | 9.96e-01 |
| SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 9.96e-01 | -0.001020 | 9.96e-01 |
| NOD1 2 SIGNALING PATHWAY | 35 | 9.94e-01 | 0.000765 | 9.96e-01 |
| ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 95 | 9.90e-01 | 0.000742 | 9.94e-01 |
| NERVOUS SYSTEM DEVELOPMENT | 554 | 9.82e-01 | 0.000549 | 9.92e-01 |
| DISEASES OF IMMUNE SYSTEM | 27 | 9.96e-01 | -0.000495 | 9.96e-01 |
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN
| 299 | |
|---|---|
| set | ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN |
| setSize | 10 |
| pANOVA | 0.000141 |
| s.dist | -0.695 |
| p.adjustANOVA | 0.00154 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Aqp1 | -8402 |
| Hbb-bt | -8023 |
| Cyb5r4 | -7594 |
| Car4 | -6819 |
| Hba-a1 | -6349 |
| Cyb5r2 | -6138 |
| Cyb5r1 | -5444 |
| Hba-a2 | -5283 |
| Car2 | -4736 |
| Cyb5rl | 1429 |
| GeneID | Gene Rank |
|---|---|
| Aqp1 | -8402 |
| Hbb-bt | -8023 |
| Cyb5r4 | -7594 |
| Car4 | -6819 |
| Hba-a1 | -6349 |
| Cyb5r2 | -6138 |
| Cyb5r1 | -5444 |
| Hba-a2 | -5283 |
| Car2 | -4736 |
| Cyb5rl | 1429 |
ADENYLATE CYCLASE ACTIVATING PATHWAY
| 35 | |
|---|---|
| set | ADENYLATE CYCLASE ACTIVATING PATHWAY |
| setSize | 10 |
| pANOVA | 0.000195 |
| s.dist | 0.68 |
| p.adjustANOVA | 0.00203 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Adcy6 | 8807 |
| Adcy4 | 8795 |
| Adcy5 | 7460 |
| Adcy8 | 7205 |
| Adcy2 | 6106 |
| Adcy9 | 5535 |
| Adcy3 | 5523 |
| Adcy7 | 5402 |
| Gnal | 4616 |
| Adcy1 | 3287 |
| GeneID | Gene Rank |
|---|---|
| Adcy6 | 8807 |
| Adcy4 | 8795 |
| Adcy5 | 7460 |
| Adcy8 | 7205 |
| Adcy2 | 6106 |
| Adcy9 | 5535 |
| Adcy3 | 5523 |
| Adcy7 | 5402 |
| Gnal | 4616 |
| Adcy1 | 3287 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
| 817 | |
|---|---|
| set | REGULATION OF RUNX1 EXPRESSION AND ACTIVITY |
| setSize | 17 |
| pANOVA | 6.32e-05 |
| s.dist | 0.56 |
| p.adjustANOVA | 0.000809 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ago3 | 8738 |
| Tnrc6b | 8726 |
| Ago2 | 8313 |
| Tnrc6a | 8107 |
| Ptpn11 | 7387 |
| Mov10 | 7384 |
| Ago1 | 6862 |
| Pml | 6835 |
| Cdk6 | 6627 |
| Ago4 | 5781 |
| Runx1 | 5573 |
| Src | 5451 |
| Tnrc6c | 5157 |
| Ccnd2 | 3372 |
| Ccnd3 | 2218 |
| Cbfb | -2842 |
| Ccnd1 | -4876 |
| GeneID | Gene Rank |
|---|---|
| Ago3 | 8738 |
| Tnrc6b | 8726 |
| Ago2 | 8313 |
| Tnrc6a | 8107 |
| Ptpn11 | 7387 |
| Mov10 | 7384 |
| Ago1 | 6862 |
| Pml | 6835 |
| Cdk6 | 6627 |
| Ago4 | 5781 |
| Runx1 | 5573 |
| Src | 5451 |
| Tnrc6c | 5157 |
| Ccnd2 | 3372 |
| Ccnd3 | 2218 |
| Cbfb | -2842 |
| Ccnd1 | -4876 |
ENDOSOMAL VACUOLAR PATHWAY
| 283 | |
|---|---|
| set | ENDOSOMAL VACUOLAR PATHWAY |
| setSize | 10 |
| pANOVA | 0.00388 |
| s.dist | -0.527 |
| p.adjustANOVA | 0.0256 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7996 |
| B2m | -7326 |
| H2-M3 | -6895 |
| Ctsl | -6233 |
| Ctss | -5908 |
| H2-D1 | -5834 |
| H2-Q7 | -4557 |
| H2-Q2 | -3151 |
| H2-Q10 | 705 |
| Lnpep | 4487 |
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7996 |
| B2m | -7326 |
| H2-M3 | -6895 |
| Ctsl | -6233 |
| Ctss | -5908 |
| H2-D1 | -5834 |
| H2-Q7 | -4557 |
| H2-Q2 | -3151 |
| H2-Q10 | 705 |
| Lnpep | 4487 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
| 1106 | |
|---|---|
| set | TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR |
| setSize | 11 |
| pANOVA | 0.00283 |
| s.dist | -0.52 |
| p.adjustANOVA | 0.0197 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tlr3 | -7487 |
| Hsp90b1 | -6977 |
| Lgmn | -6719 |
| Ctsl | -6233 |
| Ctss | -5908 |
| Ctsb | -5445 |
| Tlr7 | -3907 |
| Cnpy3 | -3425 |
| Ctsk | -2446 |
| Unc93b1 | -991 |
| Tlr9 | 3276 |
| GeneID | Gene Rank |
|---|---|
| Tlr3 | -7487 |
| Hsp90b1 | -6977 |
| Lgmn | -6719 |
| Ctsl | -6233 |
| Ctss | -5908 |
| Ctsb | -5445 |
| Tlr7 | -3907 |
| Cnpy3 | -3425 |
| Ctsk | -2446 |
| Unc93b1 | -991 |
| Tlr9 | 3276 |
INTERACTION BETWEEN L1 AND ANKYRINS
| 461 | |
|---|---|
| set | INTERACTION BETWEEN L1 AND ANKYRINS |
| setSize | 27 |
| pANOVA | 4.35e-06 |
| s.dist | 0.511 |
| p.adjustANOVA | 8.55e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sptbn4 | 9031 |
| Nfasc | 8962 |
| Kcnq2 | 8536 |
| Sptbn5 | 8498 |
| Ank2 | 8454 |
| Scn8a | 8237 |
| Ank3 | 7702 |
| Sptb | 6944 |
| Sptan1 | 6803 |
| Sptbn2 | 6783 |
| Ank1 | 6709 |
| Sptbn1 | 6657 |
| L1cam | 6559 |
| Scn5a | 6452 |
| Scn2b | 6181 |
| Scn9a | 5418 |
| Scn7a | 3987 |
| Nrcam | 3474 |
| Scn4b | 3458 |
| Scn3a | 3400 |
| GeneID | Gene Rank |
|---|---|
| Sptbn4 | 9031 |
| Nfasc | 8962 |
| Kcnq2 | 8536 |
| Sptbn5 | 8498 |
| Ank2 | 8454 |
| Scn8a | 8237 |
| Ank3 | 7702 |
| Sptb | 6944 |
| Sptan1 | 6803 |
| Sptbn2 | 6783 |
| Ank1 | 6709 |
| Sptbn1 | 6657 |
| L1cam | 6559 |
| Scn5a | 6452 |
| Scn2b | 6181 |
| Scn9a | 5418 |
| Scn7a | 3987 |
| Nrcam | 3474 |
| Scn4b | 3458 |
| Scn3a | 3400 |
| Scn2a | 2477 |
| Scn3b | 2230 |
| Kcnq3 | 2109 |
| Scn1a | 1587 |
| Scn1b | -2545 |
| Actb | -2632 |
| Actg1 | -6189 |
RETINOID CYCLE DISEASE EVENTS
| 843 | |
|---|---|
| set | RETINOID CYCLE DISEASE EVENTS |
| setSize | 10 |
| pANOVA | 0.00739 |
| s.dist | -0.489 |
| p.adjustANOVA | 0.0422 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stra6 | -8225 |
| Abca4 | -8163 |
| Ttr | -7408 |
| Rdh5 | -6237 |
| Napepld | -5214 |
| Rdh12 | -5021 |
| Rbp1 | -3616 |
| Lrat | 787 |
| Rlbp1 | 1485 |
| Rbp4 | 2232 |
| GeneID | Gene Rank |
|---|---|
| Stra6 | -8225 |
| Abca4 | -8163 |
| Ttr | -7408 |
| Rdh5 | -6237 |
| Napepld | -5214 |
| Rdh12 | -5021 |
| Rbp1 | -3616 |
| Lrat | 787 |
| Rlbp1 | 1485 |
| Rbp4 | 2232 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
| 1035 | |
|---|---|
| set | SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES |
| setSize | 29 |
| pANOVA | 6.4e-06 |
| s.dist | -0.484 |
| p.adjustANOVA | 0.000113 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ube2w | -8355 |
| Ube2e3 | -8352 |
| Ube2g1 | -8298 |
| Ube2d1 | -8221 |
| Ube2q2 | -8178 |
| Uchl3 | -8038 |
| Ube2e1 | -7973 |
| Ube2b | -7942 |
| Ube2a | -7921 |
| Ube2l3 | -7831 |
| Ube2k | -7805 |
| Ube2d2a | -7701 |
| Ube2r2 | -5535 |
| Ube2s | -4651 |
| Otulin | -4523 |
| Cdc34 | -4472 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Ube2t | -3528 |
| Uba6 | -3395 |
| GeneID | Gene Rank |
|---|---|
| Ube2w | -8355 |
| Ube2e3 | -8352 |
| Ube2g1 | -8298 |
| Ube2d1 | -8221 |
| Ube2q2 | -8178 |
| Uchl3 | -8038 |
| Ube2e1 | -7973 |
| Ube2b | -7942 |
| Ube2a | -7921 |
| Ube2l3 | -7831 |
| Ube2k | -7805 |
| Ube2d2a | -7701 |
| Ube2r2 | -5535 |
| Ube2s | -4651 |
| Otulin | -4523 |
| Cdc34 | -4472 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Ube2t | -3528 |
| Uba6 | -3395 |
| Usp9x | -2427 |
| Ube2z | -1185 |
| Usp5 | 2235 |
| Ube2h | 2263 |
| Ube2g2 | 2747 |
| Usp7 | 2984 |
| Ubc | 3480 |
| Uba52 | 3691 |
| Uba1 | 4503 |
LGI ADAM INTERACTIONS
| 518 | |
|---|---|
| set | LGI ADAM INTERACTIONS |
| setSize | 14 |
| pANOVA | 0.00277 |
| s.dist | 0.462 |
| p.adjustANOVA | 0.0195 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Adam22 | 8016 |
| Cacng8 | 7874 |
| Stx1b | 7703 |
| Adam11 | 7573 |
| Lgi2 | 7207 |
| Stx1a | 6798 |
| Cacng4 | 6480 |
| Dlg4 | 6247 |
| Cacng3 | 5233 |
| Lgi3 | 4265 |
| Cacng2 | 3168 |
| Adam23 | 1641 |
| Lgi4 | -4756 |
| Lgi1 | -6342 |
| GeneID | Gene Rank |
|---|---|
| Adam22 | 8016 |
| Cacng8 | 7874 |
| Stx1b | 7703 |
| Adam11 | 7573 |
| Lgi2 | 7207 |
| Stx1a | 6798 |
| Cacng4 | 6480 |
| Dlg4 | 6247 |
| Cacng3 | 5233 |
| Lgi3 | 4265 |
| Cacng2 | 3168 |
| Adam23 | 1641 |
| Lgi4 | -4756 |
| Lgi1 | -6342 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION
| 1176 | |
|---|---|
| set | YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION |
| setSize | 11 |
| pANOVA | 0.00997 |
| s.dist | 0.449 |
| p.adjustANOVA | 0.0537 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hipk2 | 8826 |
| Tead2 | 8492 |
| Tead3 | 8233 |
| Hipk1 | 7691 |
| Tead1 | 7226 |
| Yap1 | 6637 |
| Runx2 | 6579 |
| Tead4 | 1791 |
| Ccn2 | 1407 |
| Wwtr1 | -2220 |
| Kat2b | -7901 |
| GeneID | Gene Rank |
|---|---|
| Hipk2 | 8826 |
| Tead2 | 8492 |
| Tead3 | 8233 |
| Hipk1 | 7691 |
| Tead1 | 7226 |
| Yap1 | 6637 |
| Runx2 | 6579 |
| Tead4 | 1791 |
| Ccn2 | 1407 |
| Wwtr1 | -2220 |
| Kat2b | -7901 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT
| 158 | |
|---|---|
| set | CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT |
| setSize | 20 |
| pANOVA | 0.000516 |
| s.dist | -0.448 |
| p.adjustANOVA | 0.00482 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Atad1 | -8342 |
| Pex3 | -8048 |
| Slc25a17 | -7800 |
| Acbd5 | -7619 |
| Pex13 | -7516 |
| Abcd2 | -7513 |
| Pex2 | -7320 |
| Gdap1 | -6703 |
| Pex11b | -6362 |
| Abcd3 | -3434 |
| Aldh3a2 | -3312 |
| Pex19 | -2655 |
| Pex14 | -2364 |
| Fis1 | -2131 |
| Pxmp4 | -1092 |
| Pxmp2 | -1007 |
| Pex12 | 172 |
| Pex16 | 962 |
| Pex26 | 2534 |
| Abcd1 | 7955 |
| GeneID | Gene Rank |
|---|---|
| Atad1 | -8342 |
| Pex3 | -8048 |
| Slc25a17 | -7800 |
| Acbd5 | -7619 |
| Pex13 | -7516 |
| Abcd2 | -7513 |
| Pex2 | -7320 |
| Gdap1 | -6703 |
| Pex11b | -6362 |
| Abcd3 | -3434 |
| Aldh3a2 | -3312 |
| Pex19 | -2655 |
| Pex14 | -2364 |
| Fis1 | -2131 |
| Pxmp4 | -1092 |
| Pxmp2 | -1007 |
| Pex12 | 172 |
| Pex16 | 962 |
| Pex26 | 2534 |
| Abcd1 | 7955 |
P75NTR REGULATES AXONOGENESIS
| 679 | |
|---|---|
| set | P75NTR REGULATES AXONOGENESIS |
| setSize | 10 |
| pANOVA | 0.0152 |
| s.dist | -0.443 |
| p.adjustANOVA | 0.0735 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Omg | -7628 |
| Rhoa | -7527 |
| Mcf2 | -7459 |
| Rtn4 | -6580 |
| Rtn4r | -6460 |
| Ngf | -5442 |
| Mag | -1769 |
| Lingo1 | -243 |
| Arhgdia | 2865 |
| Ngfr | 4875 |
| GeneID | Gene Rank |
|---|---|
| Omg | -7628 |
| Rhoa | -7527 |
| Mcf2 | -7459 |
| Rtn4 | -6580 |
| Rtn4r | -6460 |
| Ngf | -5442 |
| Mag | -1769 |
| Lingo1 | -243 |
| Arhgdia | 2865 |
| Ngfr | 4875 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION
| 1069 | |
|---|---|
| set | THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION |
| setSize | 15 |
| pANOVA | 0.00318 |
| s.dist | -0.44 |
| p.adjustANOVA | 0.0214 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stra6 | -8225 |
| Abca4 | -8163 |
| Ttr | -7408 |
| Rdh11 | -6941 |
| Cyp4v3 | -6543 |
| Rdh5 | -6237 |
| Napepld | -5214 |
| Rdh12 | -5021 |
| Rbp1 | -3616 |
| Rdh10 | -2641 |
| Rdh1 | -349 |
| Lrat | 787 |
| Rlbp1 | 1485 |
| Rbp4 | 2232 |
| Myo7a | 3260 |
| GeneID | Gene Rank |
|---|---|
| Stra6 | -8225 |
| Abca4 | -8163 |
| Ttr | -7408 |
| Rdh11 | -6941 |
| Cyp4v3 | -6543 |
| Rdh5 | -6237 |
| Napepld | -5214 |
| Rdh12 | -5021 |
| Rbp1 | -3616 |
| Rdh10 | -2641 |
| Rdh1 | -349 |
| Lrat | 787 |
| Rlbp1 | 1485 |
| Rbp4 | 2232 |
| Myo7a | 3260 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
| 736 | |
|---|---|
| set | PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING |
| setSize | 11 |
| pANOVA | 0.0116 |
| s.dist | 0.44 |
| p.adjustANOVA | 0.0605 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cacna1b | 8238 |
| Cacna1e | 7552 |
| Cacna1a | 6707 |
| Cacnb3 | 6681 |
| Cacng4 | 6480 |
| Cacnb1 | 6153 |
| Cacna2d2 | 5810 |
| Cacng2 | 3168 |
| Cacnb2 | 927 |
| Cacna2d3 | 424 |
| Cacnb4 | -6238 |
| GeneID | Gene Rank |
|---|---|
| Cacna1b | 8238 |
| Cacna1e | 7552 |
| Cacna1a | 6707 |
| Cacnb3 | 6681 |
| Cacng4 | 6480 |
| Cacnb1 | 6153 |
| Cacna2d2 | 5810 |
| Cacng2 | 3168 |
| Cacnb2 | 927 |
| Cacna2d3 | 424 |
| Cacnb4 | -6238 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE
| 216 | |
|---|---|
| set | DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE |
| setSize | 20 |
| pANOVA | 0.00113 |
| s.dist | 0.421 |
| p.adjustANOVA | 0.00922 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cspg4 | 8443 |
| Ncan | 8140 |
| Gpc2 | 8054 |
| Sdc4 | 7950 |
| Agrn | 7772 |
| Bcan | 7329 |
| Gpc4 | 6870 |
| Gpc3 | 5369 |
| Sdc3 | 4437 |
| Hspg2 | 4411 |
| Gpc1 | 4370 |
| Bgn | 4058 |
| Vcan | 4052 |
| B4galt7 | 3013 |
| Gpc6 | 1263 |
| Dcn | 238 |
| Sdc1 | -59 |
| Gpc5 | -316 |
| Cspg5 | -584 |
| Sdc2 | -4724 |
| GeneID | Gene Rank |
|---|---|
| Cspg4 | 8443 |
| Ncan | 8140 |
| Gpc2 | 8054 |
| Sdc4 | 7950 |
| Agrn | 7772 |
| Bcan | 7329 |
| Gpc4 | 6870 |
| Gpc3 | 5369 |
| Sdc3 | 4437 |
| Hspg2 | 4411 |
| Gpc1 | 4370 |
| Bgn | 4058 |
| Vcan | 4052 |
| B4galt7 | 3013 |
| Gpc6 | 1263 |
| Dcn | 238 |
| Sdc1 | -59 |
| Gpc5 | -316 |
| Cspg5 | -584 |
| Sdc2 | -4724 |
CD28 DEPENDENT VAV1 PATHWAY
| 124 | |
|---|---|
| set | CD28 DEPENDENT VAV1 PATHWAY |
| setSize | 11 |
| pANOVA | 0.0175 |
| s.dist | -0.414 |
| p.adjustANOVA | 0.0817 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8020 |
| Rac1 | -7231 |
| Pak1 | -7056 |
| Cd86 | -6182 |
| Pak2 | -4849 |
| Pak3 | -3900 |
| Vav1 | -3338 |
| Grb2 | -3243 |
| Fyn | -777 |
| Lck | 2493 |
| Cd80 | 6041 |
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8020 |
| Rac1 | -7231 |
| Pak1 | -7056 |
| Cd86 | -6182 |
| Pak2 | -4849 |
| Pak3 | -3900 |
| Vav1 | -3338 |
| Grb2 | -3243 |
| Fyn | -777 |
| Lck | 2493 |
| Cd80 | 6041 |
RORA ACTIVATES GENE EXPRESSION
| 893 | |
|---|---|
| set | RORA ACTIVATES GENE EXPRESSION |
| setSize | 18 |
| pANOVA | 0.00258 |
| s.dist | 0.41 |
| p.adjustANOVA | 0.0186 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Crebbp | 8604 |
| Rxra | 8088 |
| Srebf1 | 7993 |
| Chd9 | 7486 |
| Med1 | 6809 |
| Helz2 | 6449 |
| Carm1 | 6318 |
| Ncoa6 | 5920 |
| Ep300 | 4550 |
| Ncoa1 | 4445 |
| Ppara | 4345 |
| Cpt1a | 2881 |
| Ncoa2 | 2549 |
| Smarcd3 | 1704 |
| Tbl1x | 329 |
| Tgs1 | -1318 |
| Rora | -2366 |
| Tbl1xr1 | -4334 |
| GeneID | Gene Rank |
|---|---|
| Crebbp | 8604 |
| Rxra | 8088 |
| Srebf1 | 7993 |
| Chd9 | 7486 |
| Med1 | 6809 |
| Helz2 | 6449 |
| Carm1 | 6318 |
| Ncoa6 | 5920 |
| Ep300 | 4550 |
| Ncoa1 | 4445 |
| Ppara | 4345 |
| Cpt1a | 2881 |
| Ncoa2 | 2549 |
| Smarcd3 | 1704 |
| Tbl1x | 329 |
| Tgs1 | -1318 |
| Rora | -2366 |
| Tbl1xr1 | -4334 |
MITOCHONDRIAL TRANSLATION
| 571 | |
|---|---|
| set | MITOCHONDRIAL TRANSLATION |
| setSize | 93 |
| pANOVA | 1.33e-11 |
| s.dist | -0.406 |
| p.adjustANOVA | 2.61e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mrpl1 | -8372 |
| Mrpl50 | -8312 |
| Mrpl16 | -8170 |
| Mrps30 | -8052 |
| Mrps31 | -7987 |
| Mrpl10 | -7856 |
| Mrpl40 | -7781 |
| Mrps22 | -7548 |
| Mrpl3 | -7511 |
| Mrpl32 | -7226 |
| Mrps23 | -7168 |
| Mrpl47 | -7048 |
| Mrpl22 | -6888 |
| Mrps2 | -6767 |
| Mrps14 | -6370 |
| Mrpl17 | -6224 |
| Mrpl15 | -5891 |
| Mrpl13 | -5815 |
| Mrpl34 | -5625 |
| Ptcd3 | -5530 |
| GeneID | Gene Rank |
|---|---|
| Mrpl1 | -8372 |
| Mrpl50 | -8312 |
| Mrpl16 | -8170 |
| Mrps30 | -8052 |
| Mrps31 | -7987 |
| Mrpl10 | -7856 |
| Mrpl40 | -7781 |
| Mrps22 | -7548 |
| Mrpl3 | -7511 |
| Mrpl32 | -7226 |
| Mrps23 | -7168 |
| Mrpl47 | -7048 |
| Mrpl22 | -6888 |
| Mrps2 | -6767 |
| Mrps14 | -6370 |
| Mrpl17 | -6224 |
| Mrpl15 | -5891 |
| Mrpl13 | -5815 |
| Mrpl34 | -5625 |
| Ptcd3 | -5530 |
| Mrpl30 | -5476 |
| Mrpl49 | -5416 |
| Mrpl27 | -5405 |
| Mrpl57 | -5306 |
| Chchd1 | -5288 |
| Mrpl42 | -5157 |
| Mrps18c | -5113 |
| Mrpl48 | -5075 |
| Mrpl33 | -5053 |
| Mrpl39 | -5003 |
| Mrpl11 | -4959 |
| Mrpl9 | -4954 |
| Mtif2 | -4873 |
| Mrpl46 | -4657 |
| Mrps36 | -4593 |
| Mrps17 | -4525 |
| Oxa1l | -4513 |
| Mrrf | -4421 |
| Tsfm | -4308 |
| Mrps33 | -4133 |
| Mrps27 | -3957 |
| Mrps18b | -3859 |
| Mrpl44 | -3828 |
| Mtif3 | -3813 |
| Mrpl18 | -3701 |
| Gadd45gip1 | -3617 |
| Mrpl54 | -3558 |
| Mrps26 | -3547 |
| Mrps10 | -3545 |
| Mrps28 | -3440 |
| Mrpl28 | -3315 |
| Mrpl43 | -3304 |
| Mrps18a | -3226 |
| Mrpl12 | -3216 |
| Mrpl20 | -3205 |
| Mrpl19 | -3155 |
| Mrps16 | -3110 |
| Mrpl51 | -3044 |
| Mrps25 | -3036 |
| Mrpl21 | -2960 |
| Mrps15 | -2949 |
| Mrpl52 | -2883 |
| Mrpl35 | -2863 |
| Mrps12 | -2693 |
| Mrpl2 | -2584 |
| Mrps7 | -2517 |
| Mrps9 | -2491 |
| Mrps24 | -2225 |
| Mrpl23 | -2048 |
| Mrpl41 | -1998 |
| Mrpl53 | -1939 |
| Mrpl55 | -1656 |
| Mrpl58 | -1627 |
| Mrpl24 | -1572 |
| Mrpl36 | -1429 |
| Mrps21 | -804 |
| Mrpl14 | -667 |
| Mrps5 | -163 |
| Mrps11 | -100 |
| Mrps34 | 384 |
| Aurkaip1 | 385 |
| Mrpl37 | 403 |
| Mrps6 | 685 |
| Mrps35 | 1577 |
| Mrpl38 | 2985 |
| Eral1 | 3185 |
| Gfm1 | 3942 |
| Tufm | 4206 |
| Mtfmt | 5091 |
| Dap3 | 5540 |
| Mtrf1l | 5671 |
| Mrpl4 | 5960 |
| Gfm2 | 7012 |
RECEPTOR MEDIATED MITOPHAGY
| 778 | |
|---|---|
| set | RECEPTOR MEDIATED MITOPHAGY |
| setSize | 11 |
| pANOVA | 0.02 |
| s.dist | -0.405 |
| p.adjustANOVA | 0.0888 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Atg12 | -8205 |
| Fundc1 | -8009 |
| Atg5 | -7837 |
| Pgam5 | -6808 |
| Csnk2a2 | -5327 |
| Map1lc3b | -4660 |
| Csnk2b | -4346 |
| Csnk2a1 | -2182 |
| Map1lc3a | -854 |
| Src | 5451 |
| Ulk1 | 7554 |
| GeneID | Gene Rank |
|---|---|
| Atg12 | -8205 |
| Fundc1 | -8009 |
| Atg5 | -7837 |
| Pgam5 | -6808 |
| Csnk2a2 | -5327 |
| Map1lc3b | -4660 |
| Csnk2b | -4346 |
| Csnk2a1 | -2182 |
| Map1lc3a | -854 |
| Src | 5451 |
| Ulk1 | 7554 |
CRISTAE FORMATION
| 187 | |
|---|---|
| set | CRISTAE FORMATION |
| setSize | 31 |
| pANOVA | 0.000104 |
| s.dist | -0.403 |
| p.adjustANOVA | 0.00123 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Apoo | -8139 |
| Atp5c1 | -8076 |
| Mtx2 | -8034 |
| Atp5pb | -7499 |
| Dmac2l | -7278 |
| Mtx1 | -5733 |
| Apool | -5527 |
| mt-Atp6 | -5071 |
| Atp5b | -4886 |
| Atp5h | -4812 |
| Atp5o | -4698 |
| Atp5l | -4684 |
| Chchd3 | -4637 |
| Atp5a1 | -4502 |
| Atp5g3 | -4458 |
| Immt | -3534 |
| Tmem11 | -3471 |
| Hspa9 | -3340 |
| Chchd6 | -3296 |
| Micos10 | -3146 |
| GeneID | Gene Rank |
|---|---|
| Apoo | -8139 |
| Atp5c1 | -8076 |
| Mtx2 | -8034 |
| Atp5pb | -7499 |
| Dmac2l | -7278 |
| Mtx1 | -5733 |
| Apool | -5527 |
| mt-Atp6 | -5071 |
| Atp5b | -4886 |
| Atp5h | -4812 |
| Atp5o | -4698 |
| Atp5l | -4684 |
| Chchd3 | -4637 |
| Atp5a1 | -4502 |
| Atp5g3 | -4458 |
| Immt | -3534 |
| Tmem11 | -3471 |
| Hspa9 | -3340 |
| Chchd6 | -3296 |
| Micos10 | -3146 |
| Atp5g2 | -3059 |
| Micos13 | -2576 |
| Atp5j2 | -1520 |
| Atp5e | -1120 |
| Atp5j | -1104 |
| Atp5d | 320 |
| Samm50 | 900 |
| Atp5g1 | 1349 |
| Atp5k | 2050 |
| Dnajc11 | 3708 |
| mt-Atp8 | 7353 |
BRANCHED CHAIN AMINO ACID CATABOLISM
| 103 | |
|---|---|
| set | BRANCHED CHAIN AMINO ACID CATABOLISM |
| setSize | 21 |
| pANOVA | 0.00153 |
| s.dist | -0.399 |
| p.adjustANOVA | 0.012 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Dld | -8190 |
| Acat1 | -7989 |
| Hibadh | -7679 |
| Acad8 | -7620 |
| Mccc2 | -6938 |
| Bckdhb | -6748 |
| Echs1 | -6634 |
| Aldh6a1 | -6447 |
| Hibch | -5886 |
| Acadsb | -5537 |
| Ppm1k | -5382 |
| Auh | -5364 |
| Dbt | -4509 |
| Hsd17b10 | -4464 |
| Bckdk | -4353 |
| Bckdha | 779 |
| Slc25a44 | 3735 |
| Bcat1 | 5066 |
| Bcat2 | 5464 |
| Ivd | 5519 |
| GeneID | Gene Rank |
|---|---|
| Dld | -8190 |
| Acat1 | -7989 |
| Hibadh | -7679 |
| Acad8 | -7620 |
| Mccc2 | -6938 |
| Bckdhb | -6748 |
| Echs1 | -6634 |
| Aldh6a1 | -6447 |
| Hibch | -5886 |
| Acadsb | -5537 |
| Ppm1k | -5382 |
| Auh | -5364 |
| Dbt | -4509 |
| Hsd17b10 | -4464 |
| Bckdk | -4353 |
| Bckdha | 779 |
| Slc25a44 | 3735 |
| Bcat1 | 5066 |
| Bcat2 | 5464 |
| Ivd | 5519 |
| Mccc1 | 6999 |
PENTOSE PHOSPHATE PATHWAY
| 685 | |
|---|---|
| set | PENTOSE PHOSPHATE PATHWAY |
| setSize | 13 |
| pANOVA | 0.013 |
| s.dist | -0.398 |
| p.adjustANOVA | 0.0652 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prps2 | -8270 |
| Rpe | -7876 |
| Rbks | -7612 |
| Taldo1 | -6865 |
| Pgm2 | -6624 |
| Prps1 | -4907 |
| Shpk | -2539 |
| G6pdx | -1632 |
| Tkt | -961 |
| Pgls | -216 |
| Dera | 1612 |
| Pgd | 1849 |
| Rpia | 3207 |
| GeneID | Gene Rank |
|---|---|
| Prps2 | -8270 |
| Rpe | -7876 |
| Rbks | -7612 |
| Taldo1 | -6865 |
| Pgm2 | -6624 |
| Prps1 | -4907 |
| Shpk | -2539 |
| G6pdx | -1632 |
| Tkt | -961 |
| Pgls | -216 |
| Dera | 1612 |
| Pgd | 1849 |
| Rpia | 3207 |
METABOLISM OF POLYAMINES
| 552 | |
|---|---|
| set | METABOLISM OF POLYAMINES |
| setSize | 58 |
| pANOVA | 1.59e-07 |
| s.dist | -0.398 |
| p.adjustANOVA | 6.05e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Nqo1 | -7892 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Sms | -7762 |
| Amd1 | -7587 |
| Psma6 | -7580 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Azin1 | -6577 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Paox | -5468 |
| Psmb7 | -5401 |
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Nqo1 | -7892 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Sms | -7762 |
| Amd1 | -7587 |
| Psma6 | -7580 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Azin1 | -6577 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Paox | -5468 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| Psma4 | -4815 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Psma3 | -4517 |
| Srm | -4333 |
| Odc1 | -4329 |
| Sat1 | -4125 |
| Psme2 | -4121 |
| Psma7 | -3980 |
| Oaz2 | -3954 |
| Psma8 | -3884 |
| Psmd9 | -3332 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Psmb10 | -2155 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Psmc5 | -1555 |
| Oaz1 | -1519 |
| Psmb4 | -1483 |
| Azin2 | -406 |
| Psmd11 | -127 |
| Psmc4 | 123 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Psmd7 | 1453 |
| Agmat | 1868 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Psme4 | 3590 |
| Oaz3 | 6299 |
| Smox | 8841 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
| 179 | |
|---|---|
| set | COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING |
| setSize | 26 |
| pANOVA | 0.000446 |
| s.dist | -0.398 |
| p.adjustANOVA | 0.00428 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Vbp1 | -8262 |
| Cct6a | -7953 |
| Tuba1c | -7927 |
| Cct4 | -7432 |
| Pfdn4 | -7390 |
| Tcp1 | -7383 |
| Cct2 | -6966 |
| Cct5 | -5869 |
| Cct7 | -5850 |
| Cct8 | -5469 |
| Tuba8 | -4989 |
| Tuba1b | -4438 |
| Pfdn1 | -4319 |
| Tuba4a | -3800 |
| Cct3 | -2878 |
| Tubb4b | -2642 |
| Actb | -2632 |
| Pfdn5 | -2071 |
| Tuba1a | -1728 |
| Pfdn6 | -1533 |
| GeneID | Gene Rank |
|---|---|
| Vbp1 | -8262 |
| Cct6a | -7953 |
| Tuba1c | -7927 |
| Cct4 | -7432 |
| Pfdn4 | -7390 |
| Tcp1 | -7383 |
| Cct2 | -6966 |
| Cct5 | -5869 |
| Cct7 | -5850 |
| Cct8 | -5469 |
| Tuba8 | -4989 |
| Tuba1b | -4438 |
| Pfdn1 | -4319 |
| Tuba4a | -3800 |
| Cct3 | -2878 |
| Tubb4b | -2642 |
| Actb | -2632 |
| Pfdn5 | -2071 |
| Tuba1a | -1728 |
| Pfdn6 | -1533 |
| Tubb3 | 483 |
| Tubb2a | 880 |
| Pfdn2 | 4037 |
| Tubb2b | 4298 |
| Tubb4a | 4734 |
| Tubb6 | 5550 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING
| 611 | |
|---|---|
| set | NEGATIVE REGULATION OF NOTCH4 SIGNALING |
| setSize | 54 |
| pANOVA | 4.32e-07 |
| s.dist | -0.398 |
| p.adjustANOVA | 1.34e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Ywhaz | -6972 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| Psma4 | -4815 |
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Ywhaz | -6972 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| Psma4 | -4815 |
| Rbx1 | -4727 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Psma3 | -4517 |
| Fbxw7 | -4341 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Psme2 | -4121 |
| Psma7 | -3980 |
| Psmd9 | -3332 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Psmb10 | -2155 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Tacc3 | -1588 |
| Psmc5 | -1555 |
| Psmb4 | -1483 |
| Psmd11 | -127 |
| Psmc4 | 123 |
| Akt1 | 440 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Psmd7 | 1453 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Ubc | 3480 |
| Uba52 | 3691 |
| Notch4 | 8969 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
| 340 | |
|---|---|
| set | FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC |
| setSize | 19 |
| pANOVA | 0.00278 |
| s.dist | -0.396 |
| p.adjustANOVA | 0.0195 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cct6a | -7953 |
| Tuba1c | -7927 |
| Cct4 | -7432 |
| Tcp1 | -7383 |
| Cct2 | -6966 |
| Cct5 | -5869 |
| Cct7 | -5850 |
| Cct8 | -5469 |
| Tuba8 | -4989 |
| Tuba1b | -4438 |
| Tuba4a | -3800 |
| Cct3 | -2878 |
| Tubb4b | -2642 |
| Tuba1a | -1728 |
| Tubb3 | 483 |
| Tubb2a | 880 |
| Tubb2b | 4298 |
| Tubb4a | 4734 |
| Tubb6 | 5550 |
| GeneID | Gene Rank |
|---|---|
| Cct6a | -7953 |
| Tuba1c | -7927 |
| Cct4 | -7432 |
| Tcp1 | -7383 |
| Cct2 | -6966 |
| Cct5 | -5869 |
| Cct7 | -5850 |
| Cct8 | -5469 |
| Tuba8 | -4989 |
| Tuba1b | -4438 |
| Tuba4a | -3800 |
| Cct3 | -2878 |
| Tubb4b | -2642 |
| Tuba1a | -1728 |
| Tubb3 | 483 |
| Tubb2a | 880 |
| Tubb2b | 4298 |
| Tubb4a | 4734 |
| Tubb6 | 5550 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX
| 77 | |
|---|---|
| set | ASSEMBLY OF THE PRE REPLICATIVE COMPLEX |
| setSize | 65 |
| pANOVA | 3.29e-08 |
| s.dist | -0.396 |
| p.adjustANOVA | 1.69e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Orc5 | -7806 |
| Orc6 | -7773 |
| Psma6 | -7580 |
| Orc4 | -7371 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Mcm3 | -7063 |
| Psmf1 | -7032 |
| E2f2 | -6976 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Orc2 | -5807 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Orc5 | -7806 |
| Orc6 | -7773 |
| Psma6 | -7580 |
| Orc4 | -7371 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Mcm3 | -7063 |
| Psmf1 | -7032 |
| E2f2 | -6976 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Orc2 | -5807 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| Psma4 | -4815 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Psma3 | -4517 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Psme2 | -4121 |
| E2f3 | -4111 |
| Mcm4 | -4077 |
| Psma7 | -3980 |
| Psma8 | -3884 |
| Mcm5 | -3618 |
| Psmd9 | -3332 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Mcm8 | -2252 |
| Psmb10 | -2155 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Psmc5 | -1555 |
| Psmb4 | -1483 |
| Orc3 | -1296 |
| Mcm6 | -1096 |
| Cdt1 | -1095 |
| Gmnn | -591 |
| Psmd11 | -127 |
| Mcm2 | -30 |
| Psmc4 | 123 |
| Mcm7 | 442 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Psmd7 | 1453 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Ubc | 3480 |
| Psme4 | 3590 |
| Uba52 | 3691 |
| E2f1 | 3868 |
SIGNALING BY LEPTIN
| 967 | |
|---|---|
| set | SIGNALING BY LEPTIN |
| setSize | 10 |
| pANOVA | 0.0301 |
| s.dist | 0.396 |
| p.adjustANOVA | 0.118 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sh2b1 | 8845 |
| Stat3 | 7899 |
| Ptpn11 | 7387 |
| Stat5b | 5594 |
| Stat5a | 4171 |
| Irs1 | 3445 |
| Irs2 | 3242 |
| Socs3 | 2059 |
| Jak2 | -2188 |
| Lepr | -2548 |
| GeneID | Gene Rank |
|---|---|
| Sh2b1 | 8845 |
| Stat3 | 7899 |
| Ptpn11 | 7387 |
| Stat5b | 5594 |
| Stat5a | 4171 |
| Irs1 | 3445 |
| Irs2 | 3242 |
| Socs3 | 2059 |
| Jak2 | -2188 |
| Lepr | -2548 |
TIGHT JUNCTION INTERACTIONS
| 1081 | |
|---|---|
| set | TIGHT JUNCTION INTERACTIONS |
| setSize | 17 |
| pANOVA | 0.00474 |
| s.dist | -0.396 |
| p.adjustANOVA | 0.0304 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cldn2 | -8385 |
| Cldn1 | -7898 |
| Cldn10 | -7694 |
| Crb3 | -7193 |
| Pals1 | -6579 |
| Cldn23 | -4946 |
| Pard6a | -4738 |
| F11r | -4695 |
| Cldn14 | -3402 |
| Cldn12 | -2380 |
| Cldn11 | -2050 |
| Pard6g | -1513 |
| Prkci | -1137 |
| Pard6b | -920 |
| Cldn5 | 566 |
| Patj | 2870 |
| Pard3 | 7067 |
| GeneID | Gene Rank |
|---|---|
| Cldn2 | -8385 |
| Cldn1 | -7898 |
| Cldn10 | -7694 |
| Crb3 | -7193 |
| Pals1 | -6579 |
| Cldn23 | -4946 |
| Pard6a | -4738 |
| F11r | -4695 |
| Cldn14 | -3402 |
| Cldn12 | -2380 |
| Cldn11 | -2050 |
| Pard6g | -1513 |
| Prkci | -1137 |
| Pard6b | -920 |
| Cldn5 | 566 |
| Patj | 2870 |
| Pard3 | 7067 |
UNWINDING OF DNA
| 1160 | |
|---|---|
| set | UNWINDING OF DNA |
| setSize | 12 |
| pANOVA | 0.0186 |
| s.dist | -0.392 |
| p.adjustANOVA | 0.0847 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gins4 | -7425 |
| Mcm3 | -7063 |
| Gins1 | -6211 |
| Mcm4 | -4077 |
| Mcm5 | -3618 |
| Cdc45 | -3505 |
| Mcm8 | -2252 |
| Gins2 | -1938 |
| Mcm6 | -1096 |
| Gins3 | -341 |
| Mcm2 | -30 |
| Mcm7 | 442 |
| GeneID | Gene Rank |
|---|---|
| Gins4 | -7425 |
| Mcm3 | -7063 |
| Gins1 | -6211 |
| Mcm4 | -4077 |
| Mcm5 | -3618 |
| Cdc45 | -3505 |
| Mcm8 | -2252 |
| Gins2 | -1938 |
| Mcm6 | -1096 |
| Gins3 | -341 |
| Mcm2 | -30 |
| Mcm7 | 442 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
| 189 | |
|---|---|
| set | CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES |
| setSize | 47 |
| pANOVA | 3.49e-06 |
| s.dist | -0.391 |
| p.adjustANOVA | 7.49e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Psma6 | -7580 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Fcgr1 | -5383 |
| Psmc2 | -5064 |
| Psma4 | -4815 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Psma6 | -7580 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Fcgr1 | -5383 |
| Psmc2 | -5064 |
| Psma4 | -4815 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Psma3 | -4517 |
| Psme2 | -4121 |
| Psma7 | -3980 |
| Psma8 | -3884 |
| Psmd9 | -3332 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Psmb10 | -2155 |
| Mrc1 | -1887 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Psmc5 | -1555 |
| Psmb4 | -1483 |
| Psmd11 | -127 |
| Psmc4 | 123 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Psmd7 | 1453 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Psme4 | 3590 |
| Mrc2 | 7439 |
RESPIRATORY ELECTRON TRANSPORT
| 836 | |
|---|---|
| set | RESPIRATORY ELECTRON TRANSPORT |
| setSize | 102 |
| pANOVA | 1.02e-11 |
| s.dist | -0.39 |
| p.adjustANOVA | 2.41e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sco2 | -8357 |
| Ndufaf1 | -7780 |
| Ndufaf4 | -7557 |
| Coq10b | -7517 |
| Ndufv2 | -7287 |
| Nubpl | -7180 |
| Etfdh | -7137 |
| mt-Nd2 | -7057 |
| Uqcrc2 | -7010 |
| Ndufc2 | -6893 |
| Cycs | -6845 |
| Etfa | -6716 |
| mt-Nd6 | -6545 |
| Uqcrfs1 | -6297 |
| mt-Nd4 | -6197 |
| Ndufs4 | -6192 |
| Ndufaf5 | -6126 |
| Sdhb | -6076 |
| mt-Nd1 | -5998 |
| Ndufaf2 | -5957 |
| GeneID | Gene Rank |
|---|---|
| Sco2 | -8357 |
| Ndufaf1 | -7780 |
| Ndufaf4 | -7557 |
| Coq10b | -7517 |
| Ndufv2 | -7287 |
| Nubpl | -7180 |
| Etfdh | -7137 |
| mt-Nd2 | -7057 |
| Uqcrc2 | -7010 |
| Ndufc2 | -6893 |
| Cycs | -6845 |
| Etfa | -6716 |
| mt-Nd6 | -6545 |
| Uqcrfs1 | -6297 |
| mt-Nd4 | -6197 |
| Ndufs4 | -6192 |
| Ndufaf5 | -6126 |
| Sdhb | -6076 |
| mt-Nd1 | -5998 |
| Ndufaf2 | -5957 |
| mt-Nd5 | -5921 |
| Ndufb5 | -5763 |
| Ndufs1 | -5653 |
| mt-Co1 | -5647 |
| Sdhd | -5575 |
| mt-Co2 | -5539 |
| mt-Cytb | -5502 |
| Sco1 | -5156 |
| mt-Co3 | -5129 |
| Sdhc | -5048 |
| Ndufb11 | -4979 |
| Cox7a2l | -4713 |
| Ndufs8 | -4550 |
| Uqcrh | -4429 |
| Ndufs3 | -4358 |
| Surf1 | -4315 |
| Ndufa10 | -4299 |
| Cox5a | -4288 |
| Ndufab1 | -4269 |
| Ndufb4 | -4254 |
| Ndufb9 | -4240 |
| Ndufb3 | -4238 |
| Cyc1 | -4095 |
| Etfb | -4069 |
| Ndufb8 | -3922 |
| Cox6b1 | -3860 |
| Ndufa4 | -3836 |
| Uqcrb | -3736 |
| Ndufb6 | -3352 |
| Tmem126b | -3342 |
| Cox7b | -3317 |
| Cox16 | -3255 |
| Ndufa11 | -3129 |
| Ndufb10 | -2954 |
| Cox7c | -2945 |
| Ecsit | -2884 |
| Ndufa9 | -2857 |
| Ndufs5 | -2848 |
| Cox6a1 | -2782 |
| Cox14 | -2704 |
| Coq10a | -2700 |
| Ndufa7 | -2650 |
| Ndufs2 | -2591 |
| Cox4i1 | -2505 |
| Ndufb2 | -2480 |
| Ndufc1 | -2357 |
| Cox11 | -2219 |
| Ndufa8 | -1983 |
| Uqcrc1 | -1869 |
| Cox20 | -1722 |
| Ndufv1 | -1558 |
| Ndufa2 | -1531 |
| Cox6c | -1398 |
| Ndufa5 | -1343 |
| Uqcrq | -1293 |
| Cox8a | -1268 |
| Ndufaf3 | -1245 |
| Ndufb1 | -1103 |
| Cox18 | -1099 |
| Timmdc1 | -816 |
| Sdha | -746 |
| Acad9 | -691 |
| Ndufb7 | -650 |
| Ndufa6 | -561 |
| Ndufa1 | -470 |
| Uqcr11 | -114 |
| mt-Nd3 | 257 |
| Ndufaf6 | 359 |
| Uqcr10 | 654 |
| Taco1 | 754 |
| Ndufs6 | 991 |
| Cox5b | 1153 |
| Ndufv3 | 1179 |
| Ndufa13 | 1623 |
| Cox19 | 1642 |
| Ndufa3 | 1807 |
| Ndufaf7 | 1850 |
| Ndufs7 | 1885 |
| Lrpprc | 2494 |
| Ndufa12 | 3482 |
| Trap1 | 4979 |
| Tmem186 | 6996 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1
| 1054 | |
|---|---|
| set | SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 |
| setSize | 13 |
| pANOVA | 0.0149 |
| s.dist | -0.39 |
| p.adjustANOVA | 0.0725 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Spcs3 | -7821 |
| Pax6 | -6309 |
| Spcs2 | -6276 |
| Spcs1 | -5474 |
| Tcf7l2 | -5464 |
| Sec11c | -4609 |
| Grp | -4260 |
| Dpp4 | -2461 |
| Gng13 | -1953 |
| Pcsk1 | -731 |
| Sec11a | -585 |
| Ctnnb1 | 1478 |
| Gnb3 | 4560 |
| GeneID | Gene Rank |
|---|---|
| Spcs3 | -7821 |
| Pax6 | -6309 |
| Spcs2 | -6276 |
| Spcs1 | -5474 |
| Tcf7l2 | -5464 |
| Sec11c | -4609 |
| Grp | -4260 |
| Dpp4 | -2461 |
| Gng13 | -1953 |
| Pcsk1 | -731 |
| Sec11a | -585 |
| Ctnnb1 | 1478 |
| Gnb3 | 4560 |
PHOSPHORYLATION OF THE APC C
| 699 | |
|---|---|
| set | PHOSPHORYLATION OF THE APC C |
| setSize | 18 |
| pANOVA | 0.00469 |
| s.dist | -0.385 |
| p.adjustANOVA | 0.0303 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ube2d1 | -8221 |
| Ube2e1 | -7973 |
| Anapc10 | -7447 |
| Cdk1 | -6989 |
| Cdc26 | -6729 |
| Cdc16 | -6482 |
| Cdc27 | -5031 |
| Ube2s | -4651 |
| Anapc7 | -4519 |
| Anapc16 | -4035 |
| Cdc23 | -3456 |
| Anapc4 | -3097 |
| Anapc15 | -2459 |
| Anapc11 | -2257 |
| Plk1 | -337 |
| Anapc1 | 5839 |
| Anapc5 | 5965 |
| Anapc2 | 7413 |
| GeneID | Gene Rank |
|---|---|
| Ube2d1 | -8221 |
| Ube2e1 | -7973 |
| Anapc10 | -7447 |
| Cdk1 | -6989 |
| Cdc26 | -6729 |
| Cdc16 | -6482 |
| Cdc27 | -5031 |
| Ube2s | -4651 |
| Anapc7 | -4519 |
| Anapc16 | -4035 |
| Cdc23 | -3456 |
| Anapc4 | -3097 |
| Anapc15 | -2459 |
| Anapc11 | -2257 |
| Plk1 | -337 |
| Anapc1 | 5839 |
| Anapc5 | 5965 |
| Anapc2 | 7413 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
| 40 | |
|---|---|
| set | ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 |
| setSize | 20 |
| pANOVA | 0.0029 |
| s.dist | -0.385 |
| p.adjustANOVA | 0.0201 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| P2ry12 | -8001 |
| Gng10 | -7642 |
| Gng11 | -6965 |
| Gnai3 | -6812 |
| Gnai1 | -6455 |
| Gng2 | -6301 |
| Gnb4 | -5817 |
| Gnb5 | -4608 |
| Gnb2 | -3579 |
| Gng12 | -3211 |
| Gng5 | -2765 |
| Gng3 | -2285 |
| Gnai2 | -2236 |
| Gng13 | -1953 |
| Gng7 | -1332 |
| Gngt2 | -973 |
| Gnb1 | -707 |
| Gng8 | 1182 |
| Gnb3 | 4560 |
| Gng4 | 5427 |
| GeneID | Gene Rank |
|---|---|
| P2ry12 | -8001 |
| Gng10 | -7642 |
| Gng11 | -6965 |
| Gnai3 | -6812 |
| Gnai1 | -6455 |
| Gng2 | -6301 |
| Gnb4 | -5817 |
| Gnb5 | -4608 |
| Gnb2 | -3579 |
| Gng12 | -3211 |
| Gng5 | -2765 |
| Gng3 | -2285 |
| Gnai2 | -2236 |
| Gng13 | -1953 |
| Gng7 | -1332 |
| Gngt2 | -973 |
| Gnb1 | -707 |
| Gng8 | 1182 |
| Gnb3 | 4560 |
| Gng4 | 5427 |
SYNAPTIC ADHESION LIKE MOLECULES
| 1033 | |
|---|---|
| set | SYNAPTIC ADHESION LIKE MOLECULES |
| setSize | 21 |
| pANOVA | 0.00231 |
| s.dist | 0.384 |
| p.adjustANOVA | 0.017 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ptprs | 8609 |
| Ptprf | 8311 |
| Grin2d | 8047 |
| Grin1 | 7424 |
| Lrfn4 | 7355 |
| Lrfn1 | 6937 |
| Grin2b | 6801 |
| Dlg4 | 6247 |
| Ptprd | 6013 |
| Flot2 | 5644 |
| Lrfn3 | 5256 |
| Grin2a | 4970 |
| Lrfn2 | 3928 |
| Gria1 | 3626 |
| Grin2c | 2567 |
| Flot1 | 2126 |
| Gria4 | 716 |
| Dlg3 | -140 |
| Gria3 | -3696 |
| Rtn3 | -6403 |
| GeneID | Gene Rank |
|---|---|
| Ptprs | 8609 |
| Ptprf | 8311 |
| Grin2d | 8047 |
| Grin1 | 7424 |
| Lrfn4 | 7355 |
| Lrfn1 | 6937 |
| Grin2b | 6801 |
| Dlg4 | 6247 |
| Ptprd | 6013 |
| Flot2 | 5644 |
| Lrfn3 | 5256 |
| Grin2a | 4970 |
| Lrfn2 | 3928 |
| Gria1 | 3626 |
| Grin2c | 2567 |
| Flot1 | 2126 |
| Gria4 | 716 |
| Dlg3 | -140 |
| Gria3 | -3696 |
| Rtn3 | -6403 |
| Dlg1 | -6962 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION
| 374 | |
|---|---|
| set | GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION |
| setSize | 31 |
| pANOVA | 0.000237 |
| s.dist | -0.381 |
| p.adjustANOVA | 0.00245 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8020 |
| Mtap | -7909 |
| Gsto1 | -7814 |
| Rap1b | -7601 |
| Tcp1 | -7383 |
| Capza1 | -7276 |
| Hnrnpdl | -6896 |
| Taldo1 | -6865 |
| Rala | -5876 |
| Arf1 | -5534 |
| Ppia | -5353 |
| Pak2 | -4849 |
| Psme2 | -4121 |
| Rplp0 | -3862 |
| Hspa9 | -3340 |
| Cfl1 | -3126 |
| Pitpna | -2996 |
| Pdcd4 | -2815 |
| Snrpa1 | -2396 |
| Aip | -2302 |
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8020 |
| Mtap | -7909 |
| Gsto1 | -7814 |
| Rap1b | -7601 |
| Tcp1 | -7383 |
| Capza1 | -7276 |
| Hnrnpdl | -6896 |
| Taldo1 | -6865 |
| Rala | -5876 |
| Arf1 | -5534 |
| Ppia | -5353 |
| Pak2 | -4849 |
| Psme2 | -4121 |
| Rplp0 | -3862 |
| Hspa9 | -3340 |
| Cfl1 | -3126 |
| Pitpna | -2996 |
| Pdcd4 | -2815 |
| Snrpa1 | -2396 |
| Aip | -2302 |
| Lcp1 | -2082 |
| Hnrnpf | -1008 |
| Hnrnpa2b1 | -975 |
| Lmnb1 | 8 |
| Bola2 | 324 |
| Sod1 | 393 |
| Sod2 | 1697 |
| Mif | 1965 |
| Cnn2 | 2192 |
| Msn | 4109 |
| Anxa2 | 6922 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE
| 1032 | |
|---|---|
| set | SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE |
| setSize | 87 |
| pANOVA | 7.74e-10 |
| s.dist | -0.381 |
| p.adjustANOVA | 5.71e-08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ube2d1 | -8221 |
| Ccne2 | -8217 |
| Psmc6 | -8204 |
| Ube2e1 | -7973 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Orc5 | -7806 |
| Orc6 | -7773 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Anapc10 | -7447 |
| Orc4 | -7371 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Mcm3 | -7063 |
| Psmf1 | -7032 |
| Cdc26 | -6729 |
| Psma1 | -6555 |
| GeneID | Gene Rank |
|---|---|
| Ube2d1 | -8221 |
| Ccne2 | -8217 |
| Psmc6 | -8204 |
| Ube2e1 | -7973 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Orc5 | -7806 |
| Orc6 | -7773 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Anapc10 | -7447 |
| Orc4 | -7371 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Mcm3 | -7063 |
| Psmf1 | -7032 |
| Cdc26 | -6729 |
| Psma1 | -6555 |
| Cdc16 | -6482 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Orc2 | -5807 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| Cdc27 | -5031 |
| Psma4 | -4815 |
| Rbx1 | -4727 |
| Ube2s | -4651 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Anapc7 | -4519 |
| Psma3 | -4517 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Psme2 | -4121 |
| Mcm4 | -4077 |
| Anapc16 | -4035 |
| Psma7 | -3980 |
| Psma8 | -3884 |
| Ccne1 | -3683 |
| Mcm5 | -3618 |
| Cdc23 | -3456 |
| Psmd9 | -3332 |
| Anapc4 | -3097 |
| Anapc15 | -2459 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Anapc11 | -2257 |
| Mcm8 | -2252 |
| Psmb10 | -2155 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Psmc5 | -1555 |
| Psmb4 | -1483 |
| Orc3 | -1296 |
| Mcm6 | -1096 |
| Cdt1 | -1095 |
| Fzr1 | -1003 |
| Skp2 | -450 |
| Psmd11 | -127 |
| Mcm2 | -30 |
| Psmc4 | 123 |
| Mcm7 | 442 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Psmd7 | 1453 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Ccna1 | 3446 |
| Ubc | 3480 |
| Psme4 | 3590 |
| Uba52 | 3691 |
| Ccna2 | 5456 |
| Anapc1 | 5839 |
| Anapc5 | 5965 |
| Cdk2 | 6752 |
| Anapc2 | 7413 |
METHYLATION
| 561 | |
|---|---|
| set | METHYLATION |
| setSize | 11 |
| pANOVA | 0.0299 |
| s.dist | -0.378 |
| p.adjustANOVA | 0.117 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gsto1 | -7814 |
| Mat2a | -7551 |
| Mat2b | -7543 |
| N6amt1 | -7197 |
| Tpmt | -6187 |
| Ahcy | -4611 |
| Comt | -4026 |
| Mtrr | -418 |
| Trmt112 | 2118 |
| As3mt | 2458 |
| Mtr | 8136 |
| GeneID | Gene Rank |
|---|---|
| Gsto1 | -7814 |
| Mat2a | -7551 |
| Mat2b | -7543 |
| N6amt1 | -7197 |
| Tpmt | -6187 |
| Ahcy | -4611 |
| Comt | -4026 |
| Mtrr | -418 |
| Trmt112 | 2118 |
| As3mt | 2458 |
| Mtr | 8136 |
ADENYLATE CYCLASE INHIBITORY PATHWAY
| 36 | |
|---|---|
| set | ADENYLATE CYCLASE INHIBITORY PATHWAY |
| setSize | 13 |
| pANOVA | 0.0183 |
| s.dist | 0.378 |
| p.adjustANOVA | 0.0847 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Adcy6 | 8807 |
| Adcy4 | 8795 |
| Adcy5 | 7460 |
| Adcy8 | 7205 |
| Adcy2 | 6106 |
| Adcy9 | 5535 |
| Adcy3 | 5523 |
| Adcy7 | 5402 |
| Gnal | 4616 |
| Adcy1 | 3287 |
| Gnai2 | -2236 |
| Gnai1 | -6455 |
| Gnai3 | -6812 |
| GeneID | Gene Rank |
|---|---|
| Adcy6 | 8807 |
| Adcy4 | 8795 |
| Adcy5 | 7460 |
| Adcy8 | 7205 |
| Adcy2 | 6106 |
| Adcy9 | 5535 |
| Adcy3 | 5523 |
| Adcy7 | 5402 |
| Gnal | 4616 |
| Adcy1 | 3287 |
| Gnai2 | -2236 |
| Gnai1 | -6455 |
| Gnai3 | -6812 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
| 1 | |
|---|---|
| set | A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS |
| setSize | 26 |
| pANOVA | 0.000917 |
| s.dist | 0.376 |
| p.adjustANOVA | 0.00766 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cspg4 | 8443 |
| Ncan | 8140 |
| Gpc2 | 8054 |
| Sdc4 | 7950 |
| Agrn | 7772 |
| Bcan | 7329 |
| Xylt2 | 6935 |
| Gpc4 | 6870 |
| Gpc3 | 5369 |
| B3gat1 | 5208 |
| Sdc3 | 4437 |
| Hspg2 | 4411 |
| Gpc1 | 4370 |
| Bgn | 4058 |
| Vcan | 4052 |
| B4galt7 | 3013 |
| Xylt1 | 2354 |
| Gpc6 | 1263 |
| B3galt6 | 288 |
| B3gat2 | 271 |
| GeneID | Gene Rank |
|---|---|
| Cspg4 | 8443 |
| Ncan | 8140 |
| Gpc2 | 8054 |
| Sdc4 | 7950 |
| Agrn | 7772 |
| Bcan | 7329 |
| Xylt2 | 6935 |
| Gpc4 | 6870 |
| Gpc3 | 5369 |
| B3gat1 | 5208 |
| Sdc3 | 4437 |
| Hspg2 | 4411 |
| Gpc1 | 4370 |
| Bgn | 4058 |
| Vcan | 4052 |
| B4galt7 | 3013 |
| Xylt1 | 2354 |
| Gpc6 | 1263 |
| B3galt6 | 288 |
| B3gat2 | 271 |
| Dcn | 238 |
| Sdc1 | -59 |
| Gpc5 | -316 |
| Cspg5 | -584 |
| B3gat3 | -1287 |
| Sdc2 | -4724 |
ORC1 REMOVAL FROM CHROMATIN
| 668 | |
|---|---|
| set | ORC1 REMOVAL FROM CHROMATIN |
| setSize | 68 |
| pANOVA | 8.69e-08 |
| s.dist | -0.375 |
| p.adjustANOVA | 3.63e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Orc5 | -7806 |
| Orc6 | -7773 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Orc4 | -7371 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Mcm3 | -7063 |
| Psmf1 | -7032 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Orc2 | -5807 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| GeneID | Gene Rank |
|---|---|
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Orc5 | -7806 |
| Orc6 | -7773 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Orc4 | -7371 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Mcm3 | -7063 |
| Psmf1 | -7032 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Orc2 | -5807 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| Psma4 | -4815 |
| Rbx1 | -4727 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Psma3 | -4517 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Psme2 | -4121 |
| Mcm4 | -4077 |
| Psma7 | -3980 |
| Psma8 | -3884 |
| Mcm5 | -3618 |
| Psmd9 | -3332 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Mcm8 | -2252 |
| Psmb10 | -2155 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Psmc5 | -1555 |
| Psmb4 | -1483 |
| Orc3 | -1296 |
| Mcm6 | -1096 |
| Cdt1 | -1095 |
| Skp2 | -450 |
| Psmd11 | -127 |
| Mcm2 | -30 |
| Psmc4 | 123 |
| Mcm7 | 442 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Psmd7 | 1453 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Ccna1 | 3446 |
| Ubc | 3480 |
| Psme4 | 3590 |
| Uba52 | 3691 |
| Ccna2 | 5456 |
| Cdk2 | 6752 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR
| 682 | |
|---|---|
| set | PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR |
| setSize | 20 |
| pANOVA | 0.00373 |
| s.dist | -0.375 |
| p.adjustANOVA | 0.0247 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rfc3 | -8029 |
| Apex1 | -7963 |
| Pole4 | -7961 |
| Pcna | -7539 |
| Pole3 | -6994 |
| Rfc4 | -6968 |
| Rpa3 | -6924 |
| Rfc5 | -4478 |
| Pold2 | -4368 |
| Rpa2 | -4351 |
| Polb | -4253 |
| Fen1 | -3967 |
| Rpa1 | -3830 |
| Pold4 | -3362 |
| Pole | 152 |
| Pold3 | 2035 |
| Rfc2 | 3274 |
| Rfc1 | 3955 |
| Pold1 | 4153 |
| Lig1 | 8705 |
| GeneID | Gene Rank |
|---|---|
| Rfc3 | -8029 |
| Apex1 | -7963 |
| Pole4 | -7961 |
| Pcna | -7539 |
| Pole3 | -6994 |
| Rfc4 | -6968 |
| Rpa3 | -6924 |
| Rfc5 | -4478 |
| Pold2 | -4368 |
| Rpa2 | -4351 |
| Polb | -4253 |
| Fen1 | -3967 |
| Rpa1 | -3830 |
| Pold4 | -3362 |
| Pole | 152 |
| Pold3 | 2035 |
| Rfc2 | 3274 |
| Rfc1 | 3955 |
| Pold1 | 4153 |
| Lig1 | 8705 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN
| 1053 | |
|---|---|
| set | SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN |
| setSize | 12 |
| pANOVA | 0.025 |
| s.dist | -0.374 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pla2g7 | -8174 |
| Spcs3 | -7821 |
| Bche | -6522 |
| Spcs2 | -6276 |
| Spcs1 | -5474 |
| Sec11c | -4609 |
| Klf4 | -4236 |
| Pcsk1 | -731 |
| Sec11a | -585 |
| Igf1 | -186 |
| Crhr2 | 1636 |
| Ache | 7823 |
| GeneID | Gene Rank |
|---|---|
| Pla2g7 | -8174 |
| Spcs3 | -7821 |
| Bche | -6522 |
| Spcs2 | -6276 |
| Spcs1 | -5474 |
| Sec11c | -4609 |
| Klf4 | -4236 |
| Pcsk1 | -731 |
| Sec11a | -585 |
| Igf1 | -186 |
| Crhr2 | 1636 |
| Ache | 7823 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21
| 910 | |
|---|---|
| set | SCF SKP2 MEDIATED DEGRADATION OF P27 P21 |
| setSize | 59 |
| pANOVA | 7.83e-07 |
| s.dist | -0.372 |
| p.adjustANOVA | 2.2e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ccne2 | -8217 |
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Cdkn1b | -7418 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| GeneID | Gene Rank |
|---|---|
| Ccne2 | -8217 |
| Psmc6 | -8204 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Skp1 | -7764 |
| Psma6 | -7580 |
| Cul1 | -7450 |
| Cdkn1b | -7418 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Psma1 | -6555 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Psmc2 | -5064 |
| Ccnd1 | -4876 |
| Psma4 | -4815 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Psma3 | -4517 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Psme2 | -4121 |
| Psma7 | -3980 |
| Ccne1 | -3683 |
| Psmd9 | -3332 |
| Cks1b | -3106 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Psmb10 | -2155 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Psmc5 | -1555 |
| Psmb4 | -1483 |
| Skp2 | -450 |
| Psmd11 | -127 |
| Psmc4 | 123 |
| Cdk4 | 372 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Cdkn1a | 1167 |
| Psmd7 | 1453 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Ccna1 | 3446 |
| Ubc | 3480 |
| Uba52 | 3691 |
| Ccna2 | 5456 |
| Cdk2 | 6752 |
PROTEIN UBIQUITINATION
| 754 | |
|---|---|
| set | PROTEIN UBIQUITINATION |
| setSize | 70 |
| pANOVA | 7.66e-08 |
| s.dist | -0.372 |
| p.adjustANOVA | 3.34e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ube2w | -8355 |
| Ube2e3 | -8352 |
| Ube2g1 | -8298 |
| Ube2d1 | -8221 |
| Ube2v2 | -8214 |
| Ube2q2 | -8178 |
| Ube2d3 | -8173 |
| Uchl3 | -8038 |
| Ube2e1 | -7973 |
| Ube2b | -7942 |
| Ube2a | -7921 |
| Ube2l3 | -7831 |
| Ube2n | -7815 |
| Ube2k | -7805 |
| Ube2d2a | -7701 |
| Pcna | -7539 |
| Pex13 | -7516 |
| Pex2 | -7320 |
| Selenos | -7112 |
| Ube2j2 | -6881 |
| GeneID | Gene Rank |
|---|---|
| Ube2w | -8355 |
| Ube2e3 | -8352 |
| Ube2g1 | -8298 |
| Ube2d1 | -8221 |
| Ube2v2 | -8214 |
| Ube2q2 | -8178 |
| Ube2d3 | -8173 |
| Uchl3 | -8038 |
| Ube2e1 | -7973 |
| Ube2b | -7942 |
| Ube2a | -7921 |
| Ube2l3 | -7831 |
| Ube2n | -7815 |
| Ube2k | -7805 |
| Ube2d2a | -7701 |
| Pcna | -7539 |
| Pex13 | -7516 |
| Pex2 | -7320 |
| Selenos | -7112 |
| Ube2j2 | -6881 |
| Rnf181 | -6841 |
| Wdr61 | -6291 |
| Bcl10 | -6256 |
| Rnf152 | -6149 |
| Derl1 | -5942 |
| H2-D1 | -5834 |
| Ube2r2 | -5535 |
| Cdc73 | -5406 |
| H2bc6 | -5191 |
| H2bc21 | -5030 |
| Wac | -4869 |
| H2bc4 | -4786 |
| Ube2s | -4651 |
| H2-Q7 | -4557 |
| Otulin | -4523 |
| Cdc34 | -4472 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Rraga | -3744 |
| Ube2t | -3528 |
| Uba6 | -3395 |
| H2-Q2 | -3151 |
| Rad18 | -3031 |
| Leo1 | -2492 |
| Usp9x | -2427 |
| Pex14 | -2364 |
| Rnf144a | -1704 |
| Ube2z | -1185 |
| Ctr9 | -1053 |
| Pex12 | 172 |
| H2-Q10 | 705 |
| Hltf | 1250 |
| Vcp | 1694 |
| Pex10 | 2167 |
| Usp5 | 2235 |
| Shprh | 2247 |
| Ube2h | 2263 |
| Ube2g2 | 2747 |
| Usp7 | 2984 |
| Ubc | 3480 |
| H2bc12 | 3667 |
| Uba52 | 3691 |
| Rnf40 | 4188 |
| Uba1 | 4503 |
| Paf1 | 4791 |
| Pex5 | 5912 |
| Tmem129 | 5961 |
| Rtf1 | 6095 |
| Prkdc | 7225 |
| Rnf20 | 9017 |
PROCESSING AND ACTIVATION OF SUMO
| 738 | |
|---|---|
| set | PROCESSING AND ACTIVATION OF SUMO |
| setSize | 10 |
| pANOVA | 0.0422 |
| s.dist | -0.371 |
| p.adjustANOVA | 0.147 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sumo2 | -7743 |
| Sumo1 | -7652 |
| Rwdd3 | -6572 |
| Sumo3 | -5431 |
| Uba2 | -4592 |
| Senp2 | -2623 |
| Ube2i | -2351 |
| Sae1 | -35 |
| Senp5 | 2142 |
| Senp1 | 5794 |
| GeneID | Gene Rank |
|---|---|
| Sumo2 | -7743 |
| Sumo1 | -7652 |
| Rwdd3 | -6572 |
| Sumo3 | -5431 |
| Uba2 | -4592 |
| Senp2 | -2623 |
| Ube2i | -2351 |
| Sae1 | -35 |
| Senp5 | 2142 |
| Senp1 | 5794 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
| 331 | |
|---|---|
| set | FORMATION OF ATP BY CHEMIOSMOTIC COUPLING |
| setSize | 18 |
| pANOVA | 0.00698 |
| s.dist | -0.367 |
| p.adjustANOVA | 0.0403 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Atp5c1 | -8076 |
| Atp5pb | -7499 |
| Dmac2l | -7278 |
| mt-Atp6 | -5071 |
| Atp5b | -4886 |
| Atp5h | -4812 |
| Atp5o | -4698 |
| Atp5l | -4684 |
| Atp5a1 | -4502 |
| Atp5g3 | -4458 |
| Atp5g2 | -3059 |
| Atp5j2 | -1520 |
| Atp5e | -1120 |
| Atp5j | -1104 |
| Atp5d | 320 |
| Atp5g1 | 1349 |
| Atp5k | 2050 |
| mt-Atp8 | 7353 |
| GeneID | Gene Rank |
|---|---|
| Atp5c1 | -8076 |
| Atp5pb | -7499 |
| Dmac2l | -7278 |
| mt-Atp6 | -5071 |
| Atp5b | -4886 |
| Atp5h | -4812 |
| Atp5o | -4698 |
| Atp5l | -4684 |
| Atp5a1 | -4502 |
| Atp5g3 | -4458 |
| Atp5g2 | -3059 |
| Atp5j2 | -1520 |
| Atp5e | -1120 |
| Atp5j | -1104 |
| Atp5d | 320 |
| Atp5g1 | 1349 |
| Atp5k | 2050 |
| mt-Atp8 | 7353 |
COMPLEX I BIOGENESIS
| 170 | |
|---|---|
| set | COMPLEX I BIOGENESIS |
| setSize | 56 |
| pANOVA | 2.06e-06 |
| s.dist | -0.367 |
| p.adjustANOVA | 4.67e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ndufaf1 | -7780 |
| Ndufaf4 | -7557 |
| Ndufv2 | -7287 |
| Nubpl | -7180 |
| mt-Nd2 | -7057 |
| Ndufc2 | -6893 |
| mt-Nd6 | -6545 |
| mt-Nd4 | -6197 |
| Ndufs4 | -6192 |
| Ndufaf5 | -6126 |
| mt-Nd1 | -5998 |
| Ndufaf2 | -5957 |
| mt-Nd5 | -5921 |
| Ndufb5 | -5763 |
| Ndufs1 | -5653 |
| Ndufb11 | -4979 |
| Ndufs8 | -4550 |
| Ndufs3 | -4358 |
| Ndufa10 | -4299 |
| Ndufab1 | -4269 |
| GeneID | Gene Rank |
|---|---|
| Ndufaf1 | -7780 |
| Ndufaf4 | -7557 |
| Ndufv2 | -7287 |
| Nubpl | -7180 |
| mt-Nd2 | -7057 |
| Ndufc2 | -6893 |
| mt-Nd6 | -6545 |
| mt-Nd4 | -6197 |
| Ndufs4 | -6192 |
| Ndufaf5 | -6126 |
| mt-Nd1 | -5998 |
| Ndufaf2 | -5957 |
| mt-Nd5 | -5921 |
| Ndufb5 | -5763 |
| Ndufs1 | -5653 |
| Ndufb11 | -4979 |
| Ndufs8 | -4550 |
| Ndufs3 | -4358 |
| Ndufa10 | -4299 |
| Ndufab1 | -4269 |
| Ndufb4 | -4254 |
| Ndufb9 | -4240 |
| Ndufb3 | -4238 |
| Ndufb8 | -3922 |
| Ndufb6 | -3352 |
| Tmem126b | -3342 |
| Ndufa11 | -3129 |
| Ndufb10 | -2954 |
| Ecsit | -2884 |
| Ndufa9 | -2857 |
| Ndufs5 | -2848 |
| Ndufa7 | -2650 |
| Ndufs2 | -2591 |
| Ndufb2 | -2480 |
| Ndufc1 | -2357 |
| Ndufa8 | -1983 |
| Ndufv1 | -1558 |
| Ndufa2 | -1531 |
| Ndufa5 | -1343 |
| Ndufaf3 | -1245 |
| Ndufb1 | -1103 |
| Timmdc1 | -816 |
| Acad9 | -691 |
| Ndufb7 | -650 |
| Ndufa6 | -561 |
| Ndufa1 | -470 |
| mt-Nd3 | 257 |
| Ndufaf6 | 359 |
| Ndufs6 | 991 |
| Ndufv3 | 1179 |
| Ndufa13 | 1623 |
| Ndufa3 | 1807 |
| Ndufaf7 | 1850 |
| Ndufs7 | 1885 |
| Ndufa12 | 3482 |
| Tmem186 | 6996 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1
| 62 | |
|---|---|
| set | APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 |
| setSize | 71 |
| pANOVA | 9.26e-08 |
| s.dist | -0.367 |
| p.adjustANOVA | 3.64e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ube2d1 | -8221 |
| Psmc6 | -8204 |
| Ube2e1 | -7973 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Psma6 | -7580 |
| Anapc10 | -7447 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Cdc26 | -6729 |
| Psma1 | -6555 |
| Cdc16 | -6482 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| GeneID | Gene Rank |
|---|---|
| Ube2d1 | -8221 |
| Psmc6 | -8204 |
| Ube2e1 | -7973 |
| Psmd14 | -7965 |
| Psmd12 | -7878 |
| Psmb9 | -7862 |
| Psma6 | -7580 |
| Anapc10 | -7447 |
| Psma2 | -7177 |
| Psmd6 | -7172 |
| Psmf1 | -7032 |
| Cdc26 | -6729 |
| Psma1 | -6555 |
| Cdc16 | -6482 |
| Psmd8 | -6194 |
| Psmb8 | -6188 |
| Psma5 | -5800 |
| Psmb1 | -5506 |
| Psmd10 | -5497 |
| Psmb7 | -5401 |
| Pttg1 | -5340 |
| Psmc2 | -5064 |
| Cdc27 | -5031 |
| Aurka | -4987 |
| Psma4 | -4815 |
| Ube2s | -4651 |
| Psmd5 | -4603 |
| Psmb3 | -4590 |
| Anapc7 | -4519 |
| Psma3 | -4517 |
| Ubb | -4221 |
| Rps27a | -4124 |
| Psme2 | -4121 |
| Anapc16 | -4035 |
| Psma7 | -3980 |
| Psma8 | -3884 |
| Rb1 | -3755 |
| Cdc23 | -3456 |
| Psmd9 | -3332 |
| Anapc4 | -3097 |
| Anapc15 | -2459 |
| Psmd13 | -2449 |
| Sem1 | -2432 |
| Psme3 | -2373 |
| Psmc3 | -2347 |
| Anapc11 | -2257 |
| Psmb10 | -2155 |
| Psmc1 | -1692 |
| Psmb6 | -1661 |
| Psmb2 | -1638 |
| Psmc5 | -1555 |
| Psmb4 | -1483 |
| Fzr1 | -1003 |
| Skp2 | -450 |
| Plk1 | -337 |
| Psmd11 | -127 |
| Psmc4 | 123 |
| Psme1 | 709 |
| Psmb5 | 728 |
| Psmd1 | 1046 |
| Psmd7 | 1453 |
| Psmd4 | 2248 |
| Psmd3 | 2918 |
| Psmd2 | 3350 |
| Ubc | 3480 |
| Psme4 | 3590 |
| Uba52 | 3691 |
| Anapc1 | 5839 |
| Anapc5 | 5965 |
| Cdc20 | 6094 |
| Anapc2 | 7413 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.1 (2023-06-16)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so; LAPACK version 3.10.0
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## time zone: /usr/share/zoneinfo/Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] GGally_2.1.2 gtools_3.9.4
## [3] echarts4r_0.4.5 beeswarm_0.4.0
## [5] pkgload_1.3.2.1 vioplot_0.4.0
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.16.0 limma_3.56.2
## [11] eulerr_7.0.0 mitch_1.12.0
## [13] MASS_7.3-60 fgsea_1.26.0
## [15] gplots_3.1.3 DESeq2_1.40.2
## [17] SummarizedExperiment_1.30.2 Biobase_2.60.0
## [19] MatrixGenerics_1.12.3 matrixStats_1.0.0
## [21] GenomicRanges_1.52.0 GenomeInfoDb_1.36.2
## [23] IRanges_2.34.1 S4Vectors_0.38.1
## [25] BiocGenerics_0.46.0 reshape2_1.4.4
## [27] lubridate_1.9.2 forcats_1.0.0
## [29] stringr_1.5.0 dplyr_1.1.2
## [31] purrr_1.0.2 readr_2.1.4
## [33] tidyr_1.3.0 tibble_3.2.1
## [35] ggplot2_3.4.3 tidyverse_2.0.0
## [37] zoo_1.8-12
##
## loaded via a namespace (and not attached):
## [1] bitops_1.0-7 gridExtra_2.3 rlang_1.1.1
## [4] magrittr_2.0.3 compiler_4.3.1 polylabelr_0.2.0
## [7] systemfonts_1.0.4 vctrs_0.6.3 rvest_1.0.3
## [10] pkgconfig_2.0.3 crayon_1.5.2 fastmap_1.1.1
## [13] XVector_0.40.0 ellipsis_0.3.2 labeling_0.4.2
## [16] caTools_1.18.2 utf8_1.2.3 promises_1.2.1
## [19] rmarkdown_2.24 tzdb_0.4.0 xfun_0.40
## [22] zlibbioc_1.46.0 cachem_1.0.8 jsonlite_1.8.7
## [25] highr_0.10 later_1.3.1 DelayedArray_0.26.7
## [28] reshape_0.8.9 BiocParallel_1.34.2 parallel_4.3.1
## [31] R6_2.5.1 bslib_0.5.1 stringi_1.7.12
## [34] RColorBrewer_1.1-3 jquerylib_0.1.4 assertthat_0.2.1
## [37] Rcpp_1.0.11 knitr_1.43 httpuv_1.6.11
## [40] Matrix_1.6-1 timechange_0.2.0 tidyselect_1.2.0
## [43] rstudioapi_0.15.0 abind_1.4-5 yaml_2.3.7
## [46] codetools_0.2-19 lattice_0.21-8 plyr_1.8.8
## [49] shiny_1.7.5 withr_2.5.0 evaluate_0.21
## [52] polyclip_1.10-4 xml2_1.3.5 pillar_1.9.0
## [55] KernSmooth_2.23-22 generics_0.1.3 RCurl_1.98-1.12
## [58] hms_1.1.3 munsell_0.5.0 scales_1.2.1
## [61] xtable_1.8-4 glue_1.6.2 tools_4.3.1
## [64] data.table_1.14.8 webshot_0.5.5 locfit_1.5-9.8
## [67] fastmatch_1.1-4 cowplot_1.1.1 grid_4.3.1
## [70] colorspace_2.1-0 GenomeInfoDbData_1.2.10 cli_3.6.1
## [73] fansi_1.0.4 viridisLite_0.4.2 S4Arrays_1.0.5
## [76] svglite_2.1.1 gtable_0.3.4 sass_0.4.7
## [79] digest_0.6.33 farver_2.1.1 htmlwidgets_1.6.2
## [82] htmltools_0.5.6 lifecycle_1.0.3 httr_1.4.7
## [85] mime_0.12
END of report